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Statistical Methods for Modeling Biomarkers of Neuropsychiatric Diseases
Ming Sun
Due to a lack of a gold standard objective marker, the current practice for diag-
nosing neuropsychiatric disorders is mostly based on clinical symptoms, which may
occur in the late stage of the disease. Clinical diagnosis is also subject to high
variance due to between- and within-subject variability of patient symptomatology
and between-clinician variability. Effectively modeling disease course and making
early predictions using biomarkers and subtle clinical signs are critical and challeng-
ing both for improving diagnostic accuracy and designing preventive clinical trials
for neurological disorders. Leveraging the domain knowledge that certain biological
characteristics (i.e., causal genetic mutation, cognitive reserve) are part of the dis-
ease mechanism, we first propose a nonlinear model with random inflection points
depending on subject-specific characteristics to jointly estimate the trajectories of
the biomarkers. The model scales different biomarkers into comparable progression
curves with a temporal order based on the mean inflection point. Meanwhile, it as-
sesses how subject-specific characteristics affect the dynamic trajectory of different
markers, which offers information on designing preventive therapeutics and person-
alized disease management strategy. We use EM algorithm for the estimation. Ex-
tensive simulation studies are conducted. The method is applied to biomarkers in
neuroimaging, cognitive, and motor domains of Huntington’s disease.
Under the same nonlinear random effects model framework, we propose the second
model inspired by the neural mass models. Biomarkers are modeled as the average
manifestation of functioning status of neuronal ensembles. A latent liability score is
shared across biomarkers to pool information. We use EM algorithm for maximum
likelihood estimation and in the E-step a normal approximation is used to facilitate
numerical integration. The results show that some neuroimaging biomarkers are early
signs of the onset of Huntington’s disease. Finally, we develop an online tool that
provides personalized prediction of biomarker trajectory given the medical history
and baseline measurements.
The third model uses a dynamical system based on differential equations to model
the evolution of biomarkers. The dynamical system is not only useful to character-
ize the temporal patterns of the biomarkers, but also informative of the interaction
among the biomarkers. We propose a semiparametric dynamical system based on
multi-index models. For estimation and inference, we consider a two-step procedure
based on the integral equations from the proposed model. The algorithm iterates
between the estimation of the link function through splines and the estimation of
the index parameters, allowing for regularization to achieve sparsity. We prove the
model identifiability and derive the asymptotic properties of the model parameters.
A benefit of the model and the estimation approach is to pool information from
multiple subjects to construct the network of biomarkers and provide inference. We
demonstrate the empirical improvement over competing approaches with the simu-
lated gene expression data from the third DREAM challenge. It is applied to the
electroencephalogram (EEG) data and it reveals different effective connectivity of
brain networks for patients with alcohol dependence under different cognitive tasks.
Keywords: Nonlinear mixed effects model; Random inflection point; Sigmoid func-
tion; Neurological disorders; Huntington’s disease; EM algorithm; Ordinary differen-
tial equation; Multi-index model; Effective connectivity; EEG; Gene expression
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For neurodegenerative disorders (e.g., Alzheimer’s disease (AD), Parkinson’s disease
(PD), and Huntington’s disease (HD), no objective biomarker exists to define the
disease onset time. The disease diagnosis is almost exclusively built on clinical assess-
ments. It can have high variability due to between- and within-clinician variability
as well as between- and within-patient heterogeneity. Meanwhile, the pathological
process of these diseases usually starts years before the clinical symptoms and diag-
nosis based on clinical assessments can be delayed. Accurate determination of disease
stages is imperative for early diagnosis and intervention to postpone disease onset.
The concept of using measures of biological markers and subtle clinical signs for early
diagnosis has received considerable attention in the research community (Dubois et
al., 2014; Petersen et al., 2010). Many studies of neurodegenerative diseases have
collected comprehensive clinical features and biomarkers from motor, functional, cog-
nitive, and neuroimaging domains. For psychiatric disorders, the underlying brain
dysfunction mechanism is unclear. Using biomarkers that capture the macroscopic
spatial-temporal dynamics of the electromagnetic fields of the brain has opened up a
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range of new perspectives for the study of normal and disturbed brain function. It is
developing toward a new interdisciplinary field of nonlinear brain dynamics.
The biomarkers collected for these diseases and disorders fall into two categories.
The first category is longitudinal data collected from long-term disease natural history
studies where measurements are taken at scheduled visits. The patients enter the
study at different stages of diseases, and the study span of each patient is a “snapshot”
of the entire disease course. For example, the Alzheimer’s Disease Neuroimaging
Initiative (ADNI) includes a rich panel of motor tests, cognitive tests, and brain
images collected every 6 months for as long as 6 years. Two major natural history
studies of Huntington’s disease, the Prospective Huntington at Risk Observational
Study (PHAROS) and the Neurobiological Predictors of Huntington’s Disease Study
(PREDICT-HD), collected neuroimaging measures including regional brain volumes
and clinical measures in cognitive, functional, psychiatric, and motor domains during
4-7 visits within 10 years of follow-up. The time resolution for the first type of data
is on the scale of months or years. The second category of biomarkers is intensively
collected time series data, mostly arising from neuroimaging modalities measuring
neuronal activity. As an example, electroencephalogram (EEG) is recorded at a high
temporal resolution, with sampling rates between 250 and 2000 Hz. Compared with
the longitudinal data, these biomarkers have a much higher temporal resolution, and
they concurrently change in a relatively short period of time. The spatial information
is of interest, especially for studying the interaction and connectivity patterns of brain
regions that appear during experiments.
Conceptual models and computational methods have been developed to evalu-
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ate the dynamics of both types of biomarkers. For the first type, Jack et al., 2010
proposed a theoretical population-level model for AD that defined the relationship
between progression of biomarkers and cognitive impairment stages. The rationale
of the model was based on observed imaging, biofluid, and autopsy data available
at the time. The model captures the time-dependent trajectories of the five most
well-validated AD markers, including cerebrospinal fluid (CSF) β-amyloid, CSF tau,
Positron Imaging Tomography (PET) amyloid imaging, fluorodeoxyglucose uptake
on PET (FDG-PET), and structural magnetic resonance imaging (MRI) measures of
cerebral atrophy (Figure 1.1). It constructed the vertical axis on a minimum to max-
imum scale, so that each marker is scaled in relation to its full dynamic range from
values found in completely unaffected individuals to maximally abnormal values. The
model placed progressive clinical disease stage on the horizontal axis. There are two
innovative principles in this conceptual framework. First, as the disease progresses,
the markers become abnormal in a temporally ordered manner, beginning with mark-
ers of brain amyloid deposition (CSF β-amyloid and amyloid PET), progressing to
markers of neuronal damage (CSF-tau and FDG-PET), and ending with structural
MRI which detects atrophy in certain areas typical of AD. Second, biomarker curves
follow a sigmoidal shape with clinical disease stage as the horizontal axis. A sigmoidal
shape implies an initial period of acceleration and later deceleration. Later, in Jack
et al., 2013, the horizontal axis is changed to age, due to the difficulty of defining the
clinical disease stage.
Since then, multiple validation studies (Caroli, Frisoni, and Initiative, 2010; Dono-
hue et al., 2014; Sabuncu et al., 2011) demonstrated that the model proposed in Jack
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Figure 1.1: Dynamic biomarkers of the Alzheimer’s pathological cascade. Aβ is identified
by CSF Aβ42 or PET amyloid imaging. Tau-mediated neuronal injury and dysfunction are
identified by CSF tau or fluorodeoxyglucose-PET. Brain structure is measured by use of
structural MRI. Aβ=β-amyloid. MCI=mild cognitive impairment.
et al., 2010 generally fits the empirical data, and the variations and computational
methods based on the original model have been developed. However, several addi-
tional challenges remain: first, to establish the temporal order and time gap between
biomarkers from the same or different domains; second, to determine and quantify the
effect of risk factors, such as environmental factors, genetic features, brain and cog-
nitive reserves, that contribute to between-subject heterogeneity; third, to pool the
information in a systematic and biologically meaningful way, from multiple biomark-
ers with a limited number of observations, and to derive a utility score to quantify the
disease severity for an individual. Addressing these questions will facilitate clinicians
to anchor the disease diagnosis more accurately. With these general objectives in
mind, we propose a two-state model and a neural mass model, introduced in Section
1.2 and elaborated on in Chapter 2,3.
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The biomarkers of the second type, on the contrary, are collected intensively over
a short time interval, and the trajectory estimation is not of the primary interest.
Instead, understanding the interactions between biomarkers and their impact on the
dynamics of each other allows detecting the connectivity patterns of neuronal activi-
ties, and offers insights of the causes and drug targets of neuropsychiatric disorders.
In this work, we will focus on developing methods for EEG data. A rich literature
(Silva, 1998; Stam et al., 1999; Stam, 2005) suggest that nonlinear dynamical sys-
tem is a promising analytical tool for modeling EEG time series. We develop models
and estimation methods to construct a nonlinear dynamical system using semipara-
metric multi-index models that account for between-subject heterogeneity. They are
introduced in the next section and elaborated on in Chapter 4.
1.2 Introduction of the Methodologies
For longitudinal biomarkers, it is challenging to estimate trajectories because of their
nonlinearity with time. Data from each subject, meanwhile, shows substantial het-
erogeneity from various sources. Random effects at the subject level need to be
considered. Fitting nonlinear mixed effects model is known to be computationally
difficult than linear mixed effects models, and the convergence strongly depends on
the choice of initial values (Lindstrom and Bates, 1990; Pinheiro and Bates, 1995).
Existing numeric procedures approximate the log-likelihood function by Laplacian
approximation or Gaussian quadrature (Wolfinger, 1993), or use linear mixed effects
model approximation, but they become unreliable when models are highly nonlin-
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ear. Some nonlinear models and methods based on the sigmoid assumption have
been developed. For instance, the model in Donohue et al., 2014 consists of a linear
term of age capturing the long-term first-order effect, and a nonlinear function of
age capturing the higher-order changes. It assumes each patient has an unknown
subject-specific shift on the age scale representing differential of disease progression.
This method takes into account neither the subject-level covariates nor subject-level
random effects. The model of Jedynak et al., 2012 has a marker-specific intercept
and a subject-specific sigmoid function which has fixed effect on the inflection point.
It does not consider covariate either but has separate parameters for each subject.
One source of between-subject heterogeneity is cognitive reserve (CR). CR is
defined as the brain resilience to neuropathological damage and the ability to maxi-
mize performance through differential recruitment of brain networks (Bennett et al.,
2014). It is a broad concept referring to susceptibility to impairment, which varies
with individual characteristics such as increased synaptic or neuronal capacity, higher
efficiency engaging brain networks, or the use of alternative strategies. CR mediates
why some individuals better tolerate neuronal insults. It is associated with multi-
ple factors, such as genetic predisposition, education level, lifestyle, and occupation
(Stern, 2012). In analyzing biomarkers, a biologically meaningful way to incorporate
risk factors and CR is needed.
Most methods analyze each biomarker separately and rarely pool the information
from biomarkers. This is partially because of the difficulty of accommodating different
scales of biomarkers. Some methods standardize each biomarker into the percent
scale by dividing its dynamic range, which is the difference between normal values
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in unaffected individuals and maximal abnormal values in affected individuals. This
approach requires that the marker trajectories on subjects at the very beginning and
ending stages of the disease are all well-characterized (Jack et al., 2013), which can
be infeasible for some studies.
A Two-State Model with Nonlinear Transition Probability
The recent work of Jack et al., 2016a,b proposed a binary classification scheme of
biomarkers that classifies biomarkers as either normal or abnormal. It is a convenient
shorthand to facilitate communication and understanding, even though the cutpoints
can be challenging to decide.
By this notion and the guidelines of the two aforementioned principles, in Chap-
ter 2, we propose a two-state discrete model to cluster the observations into either a
relatively mild disease status or a deteriorative status. The fluctuation of the obser-
vations is a change of the underlying latent state. The transition probability from a
mild state to a deteriorative state follows a mixture of Bernoulli distributions with
the mean following a sigmoid curve. The mixing weight is determined by a resilience
parameter, representing the CR. The sigmoid curve has a subject-specific inflection
point. In addition, a linear decline is added to account for normal aging. The model
captures the discrete nature of the observed data and accommodates better the varia-
tion than the continuous models. The random subject-specific inflection point, which
is the time point where the probability of switching between the two states changes
fastest, is allowed to depend on individual features to personalize disease progres-
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sion. Meanwhile, it contains a shared latent random variable across biomarkers, and
thereby combines information.
The expectation-maximization (EM, Dempster, Laird, and Rubin, 1977) algo-
rithm is used to estimate the parameters, in which the M-step of the procedure
reduces to simple logistic regressions and least squares regressions, and the E-step
reduces to a low-dimensional integration. The formulation bypasses the difficulty of
nonlinear optimization. We evaluated proposed methods with extensive simulations
and applied them to the motivating study, PREDICT-HD, where we estimated the
trajectories of motor signs, cognitive biomarkers, and their association with a causal
gene mutation.
A Neural Mass Model to Estimate Nonlinear Trajectories
Neurodegenerative diseases are characterized by degeneration and death of neurons.
Based on this notion, the value of a biomarker can be viewed as an overall manifesta-
tion of the functioning status of neuronal populations. For each neuronal population,
we use several latent variables to describe its functioning status, which is the essential
idea of the neural mass model (Freeman, 1977; Robinson et al., 2001; Silva et al.,
1974; Stam et al., 1999). Under a nonlinear mixed effects model framework, and
with the same formulation of the random inflection point as the previous model, the
biomarker is assumed to be the proportion of normal-functioning neuronal popula-
tions multiplied by a scale parameter. We use the EM algorithm for maximum likeli-
hood estimation. In the E-step, a normal approximation of the binomial distribution
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is used to facilitate numerical integration. We performed extensive simulation stud-
ies and revisited the PREDICT-HD study. The temporal order of four neuroimaging
biomarkers is established. Lastly, an online tool that provides the prediction of the
biomarker trajectories given the medical history and baseline measurements is devel-
oped. This generative model also circumvents the computational difficulty for fitting
nonlinear mixed effects models.
A Semiparametric Model for Nonlinear Dynamical System
The previous two models rely heavily on the sigmoid assumption. Suppose we use
M(t) to represent a biomarker, a sigmoid function M(t) = 1/(1 + exp(−(t − d))) is
the solution of a nonlinear ODE:
M ′(t) = M(t)(1−M(t)), M(0) = 1/(1 + exp(d)).
This enlightens us to model the progression of biomarkers as a dynamical system.
Let M (t) = (M1(t), . . . ,Mp(t))
T denote the measurements of p biomarkers at time
t, a typical dynamical system (Robinson, 1998) assumes M ′k(t) = fk(M(t)) for
k = 1, . . . , p, where M ′k(t) is the first derivative of Mk(t), and fk is a function that de-
termines the instantaneous impact the current states of M (t) exert upon the rate of
the kth biomarker. When Mj(t) appears in the right-hand side of the kth ODE equa-
tion, it implies that the jth biomarker regulates the evolution of the kth biomarker.
A linear ODE system, i.e., fk(·) is a linear function, is often used because of
computational simplicity and interpretability. However, in many studies of complex
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biological systems, the biomarkers exhibit nonlinear evolution patterns. For exam-
ple, the nonlinearity of neuronal dynamics is empirically supported by Silva, 1998;
Valdes-Sosa et al., 2009. In studies of gene regulatory network, the rate of change
of the concentrations of gene products and proteins shows nonlinearity (Polynikis,
Hogan, and Bernardo, 2009). To generalize beyond the linear dynamical system,
recent work by Henderson and Michailidis, 2014 and Wu et al., 2014 assumed fk to
be an additive function of individual biomarkers, analogous to generalized additive
model (GAM) for nonparametric regression. Thus, the estimation became fitting a
generalized additive model by regressing M ′k(t) on a function of each component of
M(t). Since the estimation of the biomarker gradients may suffer from high vari-
ability, later Chen, Shojaie, and Witten, 2016 proposed a method named Graph
Reconstruction via Additive Differential Equation (GRADE), where fitting a regres-
sion of Mk(t) instead of M
′
k(t) showed improved asymptotic performance. On the
other hand, the dynamic causal modeling (DCM) proposed by Friston, Harrison, and
Penny, 2003 to analyze brain connectivity studies used linear approximations, or bi-
linear approximations including experimental factors, to approximate the nonlinear
dynamics in brain neuronal activities. DCM used bilinear approximation in the sense
that an input-dependent change in connectivity can be construed as a second-order
interaction between the input and activity in a source region when causing a response
in a target region. Effective connectivity, which is the notion of the influence that
one neuronal system exerts over another (Friston, 1994), can be established based on
these methods. It is important to note that a dynamic causal model is (formally)
a Bayesian dependency graph, in which the form of the dependencies among hidden
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states is described with deterministic or random differential equations, and thereby
can be subjective due to the selection of priors.
The existing approaches of ODE systems, including linear and generalized ad-
ditive models and DCM, fall short of accommodating the interactions between the
biomarkers whereas this interaction effect is ubiquitous. For example, in the gene
regulatory system, enhancement or inhibition effect between genes on the dynamic of
a target gene is common (Ackers, Johnson, and Shea, 1982). In brain networks, exci-
tatory and inhibitory interactions within populations of neurons in affecting a target
region are often observed (David et al., 2006). Another limitation is that they are
developed for analyzing single time-course data under a fixed experimental condition.
These methods face the dimensionality challenge when single time-course data is not
adequate to recover the network. To this end, in many applications, multiple sets
of data from the same system are often obtained either with random perturbation
on the initial condition, or from heterogeneous subjects, or both (e.g., gene expres-
sion data generated by different laboratories with different experimental conditions;
EEG data collected on multiple subjects). In this case, pooling information from all
samples/subjects to derive the shared network structure while allowing heterogeneity
of interaction effect can alleviate the challenges of limited information and improve
generalizability and prediction reliability.
In Chapter 4, we propose a model using semiparametric multi-index models to
estimate nonlinear ODE systems. The model is named as Integrated Index Model
for Ordinary Differential Equations (IIM-ODE). Specifically, we assume that the
multiple time-course datasets are generated from an ODE system where fk(·, ·) is a
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function of an index of biomarkers, βTkM (t), and another index of subject-specific
covariates. The multiple datasets are assumed to have random initial conditions that
are promulgated and distributed throughout the system. Striking a balance between
fully parametric and fully nonparametric modeling, the proposed model provides a
more flexible model compared to the linear ODEs and avoids the potential curse of
dimensionality. For example, when the link function belongs to a polynomial class
with at least two degrees, the proposed model introduces quadratic and cross-product
terms of M and thereby allows interactions and nonlinear structures. The impact of
the biomarkers in the system on the kth target biomarker is parsimoniously captured
by finite-dimensional parameters, βk, which can represent effective connectivity in a
brain network or regulatory effect in a gene regulatory network. In the presence of a
large number of biomarkers, Lasso penalty is introduced for βk to identify a sparse
network, and the final structure is selected by Bayesian information criterion (BIC).
On the other hand, the second index accommodates subject-level or experiment-level
heterogeneity, and thereby enables pooling information from multiple subjects. For
estimation and inference, in Section 4.2, we consider the integral functions of the
ODEs to avoid estimating derivative of the biomarkers from the noisy observations.
We develop an efficient two-stage algorithm that alternates iteration between estimat-
ing βk through a one-step estimation scheme (Bickel, 1975), and approximating the
link function fk using spline basis functions. In the one-step update, we minimize the
squared error between the observed data and the estimated integral of the derivative
function. Taylor expansion is used to approximate the link function, which results in
similar form with the DCM. The model was applied to the EEG data for alcoholic
12
patients and control subject, under different stimulations.
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Chapter 2
A Two-State Model with Nonlinear Transition Probability
2.1 Outline
In this chapter, we propose a two-state model to jointly estimate the trajectories of
biomarkers from the same domain. The model assumes that each biomarker stays
either at a mild state or a severe state, with a nonlinear transition probability increas-
ing with age. The rest of this chapter is organized as follows. Section 2.2 introduces
the model and the EM algorithm to estimate the parameters explicitly. Extensive
simulation studies are presented in Section 2.3. In Section 2.4, the model is applied
to PREDICT-HD and some novel insights into the disease progression are discussed.
2.2 Methods
For each subject, there are multiple markers repeatedly measured. Without loss
of generality, we assume a higher marker value indicates less impairment (healthier
condition), and the general trend decreases over time. Baseline covariates of each
subject are collected at the first visit. As an example, the PREDICT-HD study
collected baseline covariates including demographic variables (e.g., gender, years of
education, type of occupation), clinical assessment scores (e.g., cognitive, motor and
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functioning ability tests), cytosine-adenine-guanine (CAG) repeat length at the causal
gene (huntingtin gene) (Duyao et al., 1993), and the initial structural MRI measures.
For the kth marker measured on the ith subject at the jth time point at age tijk, the
usual linear mixed-effects model with random intercept has the form
Yijk = β
T
0kXi + β1ktijk + vik + εijk, i = 1, ..., n, j = 1, ..., nik, k = 1, ..., K,
where β0k is a vector of marker-specific parameters,Xi includes intercept and baseline
covariates Zi, β1k is the marker-specific linear trend over time, vik is the marker- and
subject-specific random effect following a normal distribution N(0, σ2vk), and εijk is
the i.i.d. random measurement error following a normal distribution, N(0, σ2εk). The
linear term with respect to time, β1ktijk, represents the long-term decline associated
with normal aging (Rentz et al., 2010) other than the pathological changes induced by
the disease. The nonlinear pathological cascade for impaired subjects is introduced
through a smooth function f(t; ξk) with unknown parameters ξk:
Yijk = β
T
0kXi + β1ktijk + f(tijk; ξk) + vik + εijk. (2.1)
Common choices of f are logistic function and probit function. For example, the
model in Donohue et al., 2014 used f(t) = a/[1 + exp(−b(t− d))] where d is the
inflection point modeled as subject-specific fixed effect.
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The Two-State Model
Model (2.1) attributes significant variability to measurement errors. Instead, we
model Yijk as a manifestation of a mixture of linear trend and a two-state system,
where at the population level, the marginal distribution of Yijk still has a sigmoidal




0kXi + β1ktijk + aikRijk + vik + εijk, aik = α
T
kXi, (2.2)
where Rijk is a binary random variable and aik = α
T
kXi is a scale parameter modeled
by Xi. aik represents the marker- and subject-specific magnitude of induced change
on Yijk by Rijk and is constrained to be positive. When Rijk = 1, the conditional
mean of Yijk lies on the line β
T
0kXi + β1ktijk + aik, whereas when Rijk = 0, it lies on
a lower line βT0kXi + β1ktijk. The formulation of Rijk is illustrated as below.
To accommodate the notion of CR, a marker- and subject-specific lower bound
of the transition probability is introduced. This lower bound is the baseline CR that
is affected by covariates Xi and time-invariant. Specifically, we introduce a latent
binary variable Qik to represent the long-term resilience or disease susceptibility. It
follows a Bernoulli distribution such that
logitP (Qik = 1|Xi) = ηTkXi.
We use cik to denote P (Qik = 1|Xi) and name it the resilience parameter. If Qik = 1,
16
the marker stays in the mild state at all time points. A high cik represents a high
brain reserve and a better likelihood of non-susceptibility. Only when Qik = 0, the
marker is under risk of deterioration, but still with a chance of normal manifestation.
Specifically, Rik := (Ri1k, . . . , Rinikk) in (2.2) is formulated as a mixture of Qik and
Hik:
Rik = Qik + (1−Qik)Hik,
where Hik = (Hi1k, . . . , Hinikk) are independent binary variables corresponding to the
nik time points. Hijk = 1 indicates a mild state and Hijk = 0 indicates a severe state.
It follows a Bernoulli distribution such that
logitP (Hijk = 1|dik) = bk(tijk − dik).
Here bk is the rate of progression. It is constrained to be negative to reflect that
P (Hijk = 1|dik), decreases with age. The inflection point age dik is the mid time-point
of the disease impairment state in probability scale (i.e., P (Hijk = 1|tijk = dik) = 12).
Smaller inflection point implies an earlier age to reach the maximal rate of change in
probability of deterioration.
The mean profile of Rijk given the inflection point is
E[Rijk|dik] = cik +
1− cik
1 + exp(−bk(tijk − dik))
(2.3)
with the upper bound equal to 1 when tijk → −∞ and the lower bound equal to
cik when tijk → +∞. Thus the resilience parameter cik represents the maximal
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expectation of abnormality of the marker k for a patient.
To build the temporal order of the K markers in disease progression, we assume
that each inflection point dik is an affine transformation of a shared latent variable
Wi for patient i:
dik = µk + χkWi, χk ≥ 0, Wi ∼ N(θTZi, 1). (2.4)
Here Wi is a latent liability score shared among markers. It represents a subject-
specific random shift from the mean inflection point µk. χk represents how strong dik
is associated with Wi. The variance of Wi is fixed at 1 and χk is constrained to be
nonnegative to ensure identifiability. The subject-specific shift measures the inherent
vulnerability of patient i reflected by the age of inflection point, which is modeled by
standardized covariates Zi. The population with the average value of covariates has
average inflection point age µk. A patient with a smaller Wi is more vulnerable, and
a marker of the patient reaches the mid point of progression at an earlier age. Wi
pools information across markers and introduces correlation between dik. It also takes
subject-specific features and unobserved latent effects into consideration to capture
both systematic and unobserved between-subject heterogeneity of disease progression.
The sets of covariates in estimating aik, cik, dik can be different, but here we assume
they are the same for simplicity of notation.
Through (2.2), (2.3) and (2.4), Yik = (Yi1k, . . . , Yinikk) given Wi have a mean level
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with both linear trend and a sigmoidal trend:




1 + exp(−bk(tijk − dik))
]
. (2.5)
By formulating observed markers Yijk as oscillating between two straight lines with
nonlinear probabilities, the marginal model (2.5) after averaging Rijk and error terms
achieves a sigmoidal shape and thus remains to be consistent with the proposed
population-level model in (Jack et al., 2010). Among all the parameters, we are
primarily interested in the estimation of inflection point dik which outlines the age
at the largest dynamic change, and secondarily, the covariate effects on the scale
parameter aik and resilience parameter cik.
Estimation Through the EM Algorithm
Directly maximizing the likelihood for the observed data (Xi,Yik) under model (2.2),
(2.3), and (2.4) is difficult due the shared component Wi. Instead, we propose an EM
algorithm to reduce a highly nonlinear optimization to simple linear and generalized
linear optimization. We first present the likelihood function of the complete data
by assuming all latent state variables are observed. In the M-step, we update the
parameters through maximizing the conditional expectation of complete data log-
likelihood ln. In the E-step, we evaluate the conditional expectation of the complete
log-likelihood given the current parameters and observed data. The algorithm iterates
between M-step and E-step till convergence.
Specifically, denote tik = (ti1k, . . . , tinikk). Treating Qik, vik, Hik, and Wi (i =
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The complete data likelihood factors into linear terms which are much easier to
optimize compared with the observed data likelihood.
M-step






i by replacing the missing data
terms by their conditional expectations to obtain the updates for the four groups
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vk, ηk and θ is straightforward since the root of the correspond-
ing score function has an analytic solution. For (γk, χ̃k) which has no analytic so-
lution, we apply one-step Newton-Raphson method to approximate the root of the
score function. The details of solving the system of score functions are given in
Appendix A.1.
E-step
Let Ê and P̂ denote the conditional expectation and probability given the observed
data and the current estimated parameters. The conditional expectations required




vk, and θ include Ê[Rijk], Ê[vik], Ê[v
2
ik], Ê[vikRijk],










γTk t̃ijk + χ̃kWi
)}m2
]
is needed in Jacobian’s function for Newton-Raphson approximation for m1 = 0, 1, 2
and m2 = 1, 2, and each of i, j, k. Since Qik, Hijk are all binary variables, their condi-
tional expectations given vik, Wi and observed data are easy to obtain. Therefore, if
the posterior densities P̂ (Qik = 1|vik,Wi), P̂ (Qik = 0, Hijk = 0|vik,Wi), and the joint
density P̂ (vik,Wi) are available, we can evaluate the conditional expectations with
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Wmi P̂ (Qik = 0, Hijk = 0|vik,Wi)P̂ (vik,Wi)dvikdWi.
The details of deriving the posterior densities and the form of Gaussian-Hermite
quadratures for vik and Wi are given in Appendix A.2.
In the E-step, the complexity of computing posterior expectation is low because
every conditional expectation conditioning on vi1, ..., viK and Wi has an explicit ex-
pression, and the two-dimensional quadrature integration needed for vik and Wi is
computationally efficient.
For implementation, we used two sets of initial values. One set begins the al-
gorithm by initializing β0k, β1k at the estimate of a linear mixed-effects model with
random intercept and fixed effect slope and αk = 0; the other set begins the algo-
rithm by initializing β0k at the estimate of linear mixed-effect model without linear
slope term and αk equals to the least square estimate from fitting the range of each
marker. Parameter µk is set at the mean of visit age, and other parameters are set
at null value. Our numeric experiment suggests that two sets of initial values lead to
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algorithm convergence with a trivial difference.
2.3 Simulation Studies
We conduct simulation studies designed closely based on the PREDICT-HD study to
examine the performance of the proposed method. We simulate four markers based
on covariates and visit age data of 619 patients from the PREDICT-HD study. The
number of measurements ranges from 4 to 12 with a median of 7, and the length
of follow-up ranges from 2.76 to 11.32 years with an average of 6.90 years. The
covariates Zi are the standardized value of baseline age, CAG repeats length, years
of education, baseline diagnosis confidence level (DCL), gender, and baseline ICV-
standardized putamen volume. DCL is a rating of 0 to 4 with 1 = normal, 4 =
motor abnormalities that are unequivocal signs of HD (> 99% confidence). We set
χk = 1, 0.8, 0.6, 0.4 and µk = 42, 43, 44, 45, and σv = 2 and σε = 1 for the four
markers. A marker with smaller χk has a relatively weaker association with the
shared latent vulnerability score Wi.
The data is simulated under three scenarios. Scenario I simulates data using
the generative mechanism in Section 2.2, which assumes the latent variable Wi is
shared across the four markers. Scenario II is designed to examine the efficiency
gain of jointly modeling, by using the same data generated from Scenario I but
fitted separately for each marker. Scenario II is equivalent to shrinking the sample
size to 1/K, and we expect some efficiency loss. In practice, the assumption of
shared information of the susceptibility of patients across markers can be violated.
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In Scenario III we jointly fit data simulated with independent Wik, k = 1, . . . , K
across markers under the same distribution N(θTZi, 1). For each of the scenario, we
generated 100 repetitions and applied the algorithm to obtain parameter estimates.
We further used 100 bootstrap replications to calculate the standard error and the
95% bootstrap confidence interval (CI) of the estimates.
In Scenario I, all parameters are consistently estimated (Table A.1, A.2): the
mean and median bias and standard error are relatively small; the standard deviation
and standard error are close, and the coverage probability (CP) of the 95% bootstrap
confidence interval is close to the nominal level. The estimated average sigmoid curves
plus linear decline by plugging in the average Zi of the sample is almost identical
to the true curves (Figure A.1 in Appendix A.3). The precise estimation of χk and
µk demonstrates the ability of the model in pooling information across markers to
estimate the inflection point ages.
Scenario II separately analyzes the four markers by ignoring the shared Wi, and its
result is compared with Scenario I to evaluate the efficiency gain of jointly modeling.
The estimation is still consistent, but the standard deviation of the 100 estimates of
µk and bk is 27% larger compared with that of jointly modeling, indicating some loss
of efficiency. Scenario III serves as a sensitivity analysis to examine how the method
performs when the assumption of shared Wi is violated. The integrated mean squared
error (IMSE), which is calculated as the integration of the absolute difference between
the true and the estimated average curves from age 20 to 80, is used to evaluate the
overall performance of the model under the three scenarios (Table 4.2). The non-
overlay area percentage is calculated as the IMSE divided by the total area between
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the asymptote lines β0kXi + β1ktijk + aik and β0kXi + β1ktijk from age 20 to 80
using true parameters. Scenario I has the best fit with the smallest non-overlay area
percentage for each marker, while the other two scenarios have increased non-overlay
area percentage by about 1 to 2%. The two choices of initial values converge to close
estimates within 0.01% of the absolute value of the parameters. The convergence
speed is fast: in about 30 iterations, the likelihood improves by no more than 0.1%.
Table 2.1: Integrated Mean Squared Error and Non-overlay Area Percentage of Three Scenarios
Scenario I Scenario II Scenario III
Marker 1 2 3 4 1 2 3 4 1 2 3 4
Non-Overlay area∗ 15.81 14.82 22.88 23.11 22.03 18.89 22.63 27.32 19.82 21.34 32.60 25.85
Non-Overlay area% † 3.0 2.0 2.4 4.7 4.2 2.6 2.3 5.6 3.8 2.9 3.4 5.3
∗: Integrated mean squared error (IMSE) computed as the absolute difference between the true and the estimated average curves.
†: IMSE divided by the total area between asymptote lines.
2.4 Application to PREDICT-HD Data
HD is an autosomal dominant neurodegenerative disease caused by the expansion of
the CAG in the huntingtin gene, and the association between CAG repeat length and
age at onset of HD is well documented (Duyao et al., 1993; MacDonald et al., 1993).
In general, the longer the CAG repeat length, the earlier the onset time is, although
substantial individual variation exists. Here, we are interested in estimating the effect
of CAG repeat length variation on the dynamic change of brain areas, clinical signs
related to motor and cognitive abilities.
In PREDICT-HD, participants were prospectively followed up to 10 years and
clinical assessments and biomarkers were continued to be collected after HD diagnosis.
The data consist of 217 patients with HD mutation (CAG≥ 36). The dropouts were
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mostly due to administrative reasons, and thereby, non-informative.
We evaluate the temporal order of the emergence of HD impairment in markers
from the motor, cognitive domains. The clinical diagnosis of HD onset is based on the
assessment of motor signs representing HD by a trained neurologist, and motor onset
is one of the most consistently agreed disease measures (Kremer and Group, 1996).
Here HD diagnosis age will be used as a validation measure to assess predictiveness
of the inflection point ages in our analysis.
We analyzed patients with HD gene mutation but without a clinical diagnosis at
the baseline visit. We chose markers that are shown to be associated with disease
progression (Paulsen et al., 2014). In cognitive domain, the Stroop color, inference,
and word test scores (Golden and Freshwater, 1978) and the Symbol Digit Modalities
Test (SDMT) score are used. In the motor domain, the three motor ability measures
used are scores of chorea, bradykinesia (brady), oculomotor (oculo) subdomains from
the Unified Huntington Disease Rating Scale (UHDRS) motor assessment. We also
applied the model separately to the total motor score (TMS), which is the sum
of the three sub-scores aforementioned and the scores from dystonia and rigidity
subdomains (explanation of the variables are in Appendix A.4). All motor scores
have an increasing trend with a higher score indicating lower motor capacity. We
use a monotone transformation, − log(x + 1), to ensure a decreasing trend in order
to compare with measures in other domains. For each marker, we include patients
with at least 4 measurements to ensure stability. For cognitive and motor domain,
the standardized covariates used are the CAG repeat length (the primary predictor
of interest), baseline age, years of education, DCL, gender, and baseline putamen
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regional volume.
The convergence criterion is set as log-likelihood increasing by no more than 0.1%
of the current value of the log-likelihood. It took about 20-30 iterations for the
algorithm to converge.
Overall Results
Figure 2.1 shows the conditional mean of Rijk as a function of t for selected markers
by plugging in the estimated parameter a, b, c when the covariates are at the mean
level and dik set at µ̂k, (i.e., a patient with disease susceptibility score Wi = 0):
E[R(t)|µ̂k] = ĉk +
1− ĉk
1 + exp(−b̂k(t− µ̂k))
. (2.6)
The result is listed in Table 2.2, Table A.3 in Appendix A.3. Overall, the inflection
point age is close for most measures, starting from brady in the motor domain, next
SDMT, Stroop inference, and word scores from the cognitive domain.
Cognitive Domain
Parameter estimates of markers from cognitive domain are shown in Table 2.2. We
bootstrapped 100 times at the subject level to estimate the standard error of each

















Figure 2.1: The estimated mean progression profile of the nonlinear component given mean
inflection point (i.e., expression (2.6)) for selected markers from PREDICT-HD study: cog-
nitive markers: SDMT, Stroop inference; Motor marker: brady, total motor score
mean covariates level of all subjects:
E[Yk(t)|µ̂k] = β0k + β1kt+ âk[ĉk +
1− ĉk
1 + exp(−b̂k(t− µ̂k))
]. (2.7)
The estimated curves adequately capture the average trend of the observed data.
The bootstrap confidence band is narrow around the inflection point while increased
variability occurs at the extremely young and old age.
The four markers in the cognitive domain have very close average inflection points
within half a year around 41-year-old, which suggests that the probability of staying in
a mild state decreases fastest at a common time window. Although Stroop word score
and SDMT decrease faster in probability with rates b = −0.92 (95%CI [−1.11,−0.72])
and −0.88 (95% CI [−1.02,−0.73]), the resilience parameters are relatively high with
c = 0.60 (95%CI [0.51, 0.68]) and 0.51 (95%CI [0.40, 0.62]), compared with c = 0.41






















































Figure 2.2: Four markers from the cognitive domain with the data from 100 random sampled
patients. The black line is the estimated mean level with a linear trend and sigmoid curve
(i.e., expression (2.7)), and the shaded area indicates bootstrap confidence interval.
One noticeable result for the cognitive domain is the significant effect of CAG on the
resilience parameter c. Figure 2.3 shows the average curve
E[R(t)|µ̂k] = ĉk +
1− ĉk
1 + exp(−b̂k(t− µ̂k))
(2.8)
by plugging in different CAG repeat lengths in ĉk, µ̂k with other covariates controlled
at the mean.
With 2 repeats increment of CAG repeat length from the mean length of 43, the
resilience parameter c decreases from 0.51 to 0.22 for SDMT, from 0.46 to 0.35 for
Stroop color score and from 0.41 to 0.35 for Stroop inference score. The estimation of
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Figure 2.3: The estimated effect of CAG repeat length by controlling other covariates at
the mean level. Black line: estimated mean progression profile of the nonlinear component
given mean inflection point (i.e., expression (2.8)). Red lines: curve with CAG level at
+1 and +2 standard deviation, controlling other covariates at the mean level. Green lines:
curve with CAG level at −1 and −2 standard deviation.
θ shows that the baseline visit age plays a bigger role in the inflection point age than
other covariates. The effect of CAG repeat length is small, which may be masked
by the strong predictive effect of baseline visit age. The four markers have a similar
value of χk around 1.3, which suggests a similar effect of Wi on their inflection point
ages.
Motor Domain
For the motor domain, the joint model is applied to the three subdomain scores
while the TMS is analyzed alone since it consists the three scores and other sub-
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domains. The estimates of the motor domain are summarized in Table A.3, Ap-
pendix A.3. Among the covariates, a high volume of putamen significantly mitigates
the scale of the deterioration, aik. The resilience parameter for oculomotor (0.28,
95%CI [0.15, 0.40]) and bradykinesia (0.16, 95%CI [0.01, 0.30]) is significantly lower
than that of chorea (0.43, 95%CI [0.31, 0.54]) while the progression rate b is larger
for oculomotor and bradykinesia. The average inflection point µk for oculomotor and
bradykinesia is about half-year earlier than that of chorea. These results suggest that
oculomotor and bradykinesia are likely to degenerate earlier and faster than chorea,
but chorea has a more detectable gap between two states. The value of parameters
χ and µ for three scores are similar, which suggests a similar effect of Wi. The prob-
ability of staying in a mild state for TMS decreases faster compared with the other
three scores, with very similar resilience parameter and covariates effect.
Comparisons of Subpopulations
The scale-free component E[Rijk|dik] automatically lies in the range of [0, 1], which
makes the comparison between markers feasible. In addition, the progression of
the disease for subpopulation with specific covariates can be evaluated. Figure 2.4
shows the estimated average nonlinear marker curves from the three domains for
subpopulation with CAG repeat length less than mean 43 (left panel), which have
much earlier and steeper decreasing trend, with a lower resilience parameter compared
with the curves for subpopulation with CAG repeat length more than 43 (right panel).
It is worth noting that both baseline volume of putamen and CAG repeat length play a
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significant role in predicting the resilience parameter c. For all domains, a patient with
longer CAG repeat length has a significantly smaller resilience probability implying
a lower brain and cognitive reserve. This offers a novel perspective of understanding
and quantifying CAG repeat length’s effect on the progression of HD.
Figure 2.4: The estimated mean progression profile of the nonlinear component given av-
erage inflection point (i.e., expression (2.3)) for subpopulations with CAG < 43 (left) and
CAG >= 43 (right) when other covariates controlled at sample mean for markers in motor
domain (upper row), cognitive domain (lower row).
Another desirable byproduct of our model is the estimation and interpretation
of the posterior knowledge of latent subject-specific vulnerability score Wi given ob-
served data, which aggregates the information from several markers for a patient.
Using the posterior density of Wi, the posterior mean of each inflection point age dik
is readily available. For example, the posterior density of dik given observed data for
putamen marker and TMS for patients who had a motor diagnosis is shown with the
heatmap (Figure 2.5).
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Figure 2.5: Posterior density of inflection points dik of marker TMS given observed data
for each patient who was diagnosed during the study. Each row represents one patient and
the x-axis is the age. The clinical diagnosis age of a patient is marked as a green dot.
For TMS, the clinical diagnosis is made right around the posterior mean of dik,
with a slight shift to the right. This corresponds to an average probability 0.44 of
staying in a mild state when a patient is clinically diagnosed, and an average patient
has experienced 56% motor impairment at the clinical diagnosis. This observation is
supported in the clinical literature where an acceleration of the motor sign is observed
right before clinical diagnosis (Paulsen et al., 2014). Using these posterior means, we
can thus rank the severity of each domain for each patient at their diagnosis age.
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2.5 Discussion
The model integrates markers measured on heterogeneous scales while mapping them
into a common latent scale to allow comparisons across domains. It circumvents this
difficulty through formulating a nonlinear model as a mixture of two latent states, each
with a linear trajectory, but with switching probability depending on time through a
nonlinear link function, a linearization of nonlinear model is achieved.
Corresponding to the “linearization” of a nonlinear model, an EM algorithm is
proposed to solve a difficult nonlinear optimization with several explicit solutions
in the M-step. The M-step of the procedure reduces to simple logistic regressions
and least squares regressions, and the E-step reduces to a low-dimensional integra-
tion, which together greatly facilitate computation and bypass the difficult nonlinear
optimization.
In the next chapter, we build a neural mass model, based on the same notion that
a biomarker is the manifestation of latent states, but the latent states come from a
large population of neurons.
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Table 2.2: Parameter Estimates of the Cognitive Markers from PREDICT-HD Data
Par Covariates SDMT s.e. Stroop Color s.e. Stroop Word s.e. Stroop Inference s.e.
β0k Intercept 63.394 2.162 86.006 2.499 111.454 4.155 46.090 2.020
T1 0.258 1.403 0.673 1.601 5.784 2.082 -1.701 0.962
CAG -2.904 1.150 -4.353 1.469 -3.787 1.864 -1.173 0.815
Gender 1.281 0.737 -2.067 1.098 0.832 1.642 0.691 0.589
Edu Yr 0.471 0.793 3.252 0.901 0.536 1.410 2.211 0.570
DCL -1.208 0.795 -1.306 0.967 -1.229 1.399 -1.773 0.601
Putamen 3.821 0.913 5.373 1.213 4.649 1.745 3.372 0.672
β1k -0.417 0.049 -0.337 0.055 -0.604 0.082 -0.096 0.045
αk Intercept 8.343 0.822 10.933 1.231 16.678 2.234 5.317 0.313
T1 -1.637 0.996 -1.612 1.415 -3.740 2.052 0.166 0.496
CAG -0.651 0.934 0.270 1.092 -0.026 1.551 0.768 0.539
Gender -0.869 0.486 3.465 1.326 1.392 1.403 -0.192 0.297
Edu Yr 2.196 0.596 0.277 0.783 0.580 1.210 0.676 0.385
DCL -0.644 0.566 -0.133 0.720 -0.861 1.130 -0.171 0.345
Putamen -0.615 0.684 -2.209 0.855 -0.303 1.345 -0.745 0.407
ηk Intercept -0.052 0.227 -0.194 0.222 0.406 0.175 -0.394 0.223
T1 -0.033 0.321 0.063 0.296 0.126 0.295 0.398 0.300
CAG -1.133 0.404 -0.416 0.321 -0.212 0.267 -0.231 0.297
Gender -0.040 0.222 0.409 0.210 0.113 0.172 0.268 0.221
Edu Yr 0.637 0.241 -0.094 0.220 0.264 0.220 -0.019 0.207
DCL -0.077 0.232 -0.553 0.234 -0.384 0.249 -0.512 0.227
Putamen 0.305 0.301 0.001 0.253 0.438 0.262 0.484 0.301
θ T1 9.514 0.307 9.514 0.307 9.514 0.307 9.514 0.307
CAG 0.302 0.289 0.302 0.289 0.302 0.289 0.302 0.289
Gender -0.161 0.214 -0.161 0.214 -0.161 0.214 -0.161 0.214
Edu Yr 0.739 0.202 0.739 0.202 0.739 0.202 0.739 0.202
DCL -0.390 0.195 -0.390 0.195 -0.390 0.195 -0.390 0.195
Putamen -0.901 0.238 -0.901 0.238 -0.901 0.238 -0.901 0.238
ck 0.507 0.054 0.463 0.054 0.600 0.044 0.412 0.053
bk -0.880 0.075 -0.707 0.074 -0.916 0.098 -0.528 0.059
µk 41.516 0.574 40.710 0.562 41.380 0.377 41.038 0.950
χk 1.360 0.071 1.381 0.071 1.243 0.060 1.311 0.094
σvk 9.161 0.381 11.191 0.598 14.451 0.691 8.444 0.360
σεk 0.832 0.081 1.034 0.095 1.220 0.118 0.804 0.072
In the table, the estimates of four markers from the cognitive domain are listed. For the kth marker, β0k is
the coefficient vector of covariates in estimating intercept; β1k is the coefficient of linear trend of time; αk is the
coefficient vector of covariates in estimating the scale parameter ak; ηk is the coefficient vector of covariates in
estimating resilience parameter cik, while ck is the resilience parameter when covariates Zi = 0; µk is the mean
inflection point of the sigmoid curve for an average subject with mean covariates, χk is the scale parameter for the
latent variable Wi; σvk and σεk are the standard deviation of the random effects and measurement error, respectively;
and θ is the shared coefficient vector of covariates in estimating Wi across markers. The s.e. column is the standard
error of bootstrap estimates.
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Chapter 3
A Neural Mass Model to Estimate Nonlinear Trajectories
3.1 Outline
In this chapter, we develop a nonlinear mixed effects model that belongs to the class
of neural mass model. In Section 3.2, we defined the model. We then described
the EM algorithm for computing the maximum likelihood estimates. In Section 3.3,
we conducted extensive simulations to demonstrate the finite-sample performance.
In Section 3.4, we revisited the PREDICT-HD to estimate temporal ordering of re-




A neural mass model uses only one or two state variables to represent the mean ac-
tivity of the whole population. This procedure, sometimes referred to as “mean-field
approximation”, is efficient for determining the steady-state behavior of neuronal
system. We estimate the biomarkers as the average manifestation of a large number
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of neuronal ensembles. A neural ensemble is a population of nervous system cells
involved in a particular neural computation (Sherrington, 1966). We borrow this no-
tion and introduce latent variables at the neural ensemble level. Let i index subject,
k index a biomarker, j index observation time point, and s index neural ensemble.
First, to incorporate CR, we define a latent binary variable, Qiks, for ensemble s
related to the kth biomarker of patient i. We assume Qiks follow a Bernoulli distri-
bution with one representing that the sth ensemble does not reach the threshold for
damage. Define cik := P (Qiks = 1) as the CR parameter representing CR capacity of
patient i, which may depend on the baseline covariates Zi. Let Xi = (1
T,ZTi )
T, we
assume logit(cik) = η
T
kXi, i = 1, ..., n; k = 1, ..., K.
Next, to model the neuronal dysfunction state at the jth time point, we introduce
binary random variable Bijks, where Bijks = 1 indicates that the ensemble is normal,
and Bijks = 0 indicates abnormal. In the non-susceptible (reserved) state with Qiks =
1, there is no risk of experiencing neuronal abnormality. Thus P (Bijks = 1|Qiks =
1) = 1 for each time point j. In the susceptible state with Qiks = 0, we assume that
the probability of maintaining a normal neuronal activity is
P (Bijks = 1|Qiks = 0, dik) = 1/{1 + exp[−bk(tijk − dik)]}, (3.1)
where tijk is the age of subject i and bk is the biomarker-specific rate which is con-
strained to be nonpositive since the probability of normal functioning decreases with
time. Furthermore, we assume that the inflection point dik is associated with co-
variates, and dik of different biomarkers for the same patient is correlated through a
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shared latent variable Wi with biomarker-specific location and scale shifts. Specifi-
cally, we model dik as:
dik = µk + χkWi, Wi ∼ N(θTZi, 1), χk ≥ 0, k = 1, ..., K. (3.2)
This random inflection point describes the subject- and biomarker-specific age when
the dynamic rate of a biomarker reaches the maximum, and, therefore, it is the age
when the change is most detectable. Note that the inflection point can be used
as the anchoring event to describe that a patient has reached the halfway of the
pathophysiological pathway as manifested by the kth biomarker.
The subject-specific latent variable Wi in (3.2) follows a normal distribution with
mean associated with standardized Zi, and, therefore, the mean of Wi is anchored
at the population-average level of covariates. It represents a latent liability score
that measures the relative severity of the disease in patients, where a patient with a
larger value indicates a milder condition and a negative value indicates a condition
more severe than the population average. The model in (3.2) allows correlation
among biomarkers, by assuming that a patient with a larger Wi will have delayed
progression of all biomarkers. The variance of Wi is set to 1 to ensure identifiability.
The parameter χk represents the magnitude of manifestation of Wi in dik which allows
a different variance of the inflection points of each biomarker, and µk is the inflection
point of the kth biomarker for an “average” patient with mean covariate values.
We assume that Qiks of each ensemble is independent and so is abnormality status
Bijks. From the generative model, the distribution of Bijks is a mixture of a point
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mass and a Bernoulli random variable:
Bijks = Qiks + (1−Qiks)Hijks (3.3)
where Hijks is independent with Qiks, and
Hijks|dik ∼ Bernoulli(1/{1 + exp[−bk(tijk − dik)]}).
Suppose that each neural ensemble at a normal state has a magnitude aik = α
T
kXi,





Bijks, subject to degeneration of normal aging and additional measurement
errors. Typically, a neural mass consists of approximately 104 to 107 neurons.
Here, the number of neural ensembles, Ni, is an auxiliary variable which does not
affect the estimation of mean activity as long as it is large enough to ensure sufficient
approximation of means of Bernoulli random variables. In other words, the observed
biomarker k at time j for subject i is formulated as





[Qiks + (1−Qiks)Hijks] + vik + εijk, (3.4)
vik ∼ N(0, σ2vk), εijk ∼ N(0, σ
2
εk),
where vik is i.i.d. subject- and biomarker-specific random effect, εijk is i.i.d. mea-
surement error, and a linear trend, βktijk, is introduced to represent the natural
degeneration associated with long term aging. Figure 3.1 illustrates the generative
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working model of different markers under several layers of latent random variables.
Figure 3.1: Didactic graph of data generative mechanism
From (3.1), (3.2), (3.4), it is clear that the conditional expectation of Yijk given
Wi is




1 + exp{−bk(tijk − µk − χkWi)}
]
, (3.5)
in which the second part of the right-hand side coincides with the sigmoidal assump-
tion of the model in (Jack et al., 2010), with an upper bound of aik when t → −∞
and a lower bound of aikcik when t → +∞. Therefore, a biomarker showing no
pathological abnormality is expected to change linearly since aik + βkt corresponds
to long term aging, while the mean of a biomarker with abnormality will start from
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the asymptote line aik +βkt, decline as a sigmoid curve, and eventually reach another
asymptote line βkt + aikcik. The additional declination is aik(1 − cik). Under some
weak assumptions, all the parameters in the proposed model are identifiable (proof
of identifiability is in Appendix B.1).
Estimation Through the EM Algorithm







s=1(1 − Qiks)Hijks, which represent the average ensemble performance, and
denote Yijk, j = 1, ..., nik as vector Yik, Rijk·, j = 1, ..., nik as vector Rik·. Note
that Qik·,Rik· and Wi are treated as missing data. We assume independence be-
tween subjects, and the conditional independence of markers from the same subject
given Wi. Thereby, the complete log-likelihood function from models (3.1)- (3.4) for


































































































likelihood function is thus the integration of exp{ln} over W and v’s and the summa-
tion over discrete variables Q’s and H’s. To obtain the maximum likelihood estimates,
we apply EM algorithm.
The E-step computes the conditional expectation of the log-likelihood of the com-
plete data with respect to the distribution of the missing data (Qik·,Rik·, vik,Wi),
given the observed data Yik, covariatesXi, i = 1, . . . , n, k = 1, . . . , K and the current
estimated parameter values. The M-step separately maximizes the four components
of the complete log-likelihood replacing the missing data terms by their conditional









vk, ηk and θ have analytic
solutions. For (bk, µk, χk) which has no analytic solution, we apply one-step Newton-
Raphson method to approximate the root of the score function. We only show the
M-step for updating (βk,αk) and (bk, µk, χk). The details of solving the system of




We denote Ê[·] as the conditional expectation given the observed data and current
estimated parameters. In the M-step, we solve the following equations to update the









XiXTi Ê[(Qik· +Rijk·)2] XiÊ[(Qik· +Rijk·)]tijk
















For bk, µk and χk, k = 1, ..., K, let γ = (γ1k, γ1k, γ1k)
T, where γ1k = bk, γ2k =












(1−Qik·) exp{γ1ktijk + γ2k + γ3kWi}(tijk, 1,Wi)T




by one-step Newton-Raphson, which requires the second derivative of the above equa-








(1−Qik·) exp{γ1ktijk + γ2k + γ3kWi}(tijk, 1,Wi)T(tijk, 1,Wi)




We denote three components of the left side of the equations (3.6) as
L1(γ), L2(γ), L3(γ), then we update γ by:
γ(new) = γ(old) − J−1[L1(γ(old)), L2(γ(old)), L3(γ(old))]T
and update bk, µk and χk using bk = γ1k, µk = −γ2k/γ1k and χk = −γ3k/γ1k.
The conditional expectations in the above equations need to be evaluated in the
E-step. However, when Ni is large, it is computationally challenging to enumerate
all possible combinations of Qiks and Rijks. We will elaborate a method to avoid the
summation over all possible Qiks and Rijks’s in the next section.
E-Step
The equations in the M-step show that all the conditional expectations take the form
of Ê [g1(Qik·, Rijk·, vik)g2(Wi)] , where both g1 and g2 are some integrable functions.
In particular, g1 is some linear or quadratic function of Qik· and Rijk· or the prod-
uct between Qik·, Rijk· and vi with order less than 2. To evaluate this conditional
expectation given observed data, we first calculate the conditional expectation given
observed data plus Wi and then take expectation with Wi:
Ê [g1(Qik·, Rijk·, vik)g2(Wi)] = Ê[Ê [g1(Qik·, Rijk·, vik)|Wi] g2(Wi)]. (3.7)
The conditional expectation of Ê [g1(Qik·, Rijk·, vik)|Wi] requires enumerating all pos-
sible combinations of Qiks and Rijks’s, which is computationally demanding. Ob-
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serving that Qiks and Rijks appear in the likelihood function in the form of Qik· and
Rijk· and by assuming a large Ni, we can approximate the averages, Qik· and Rijk·,
using multivariate normal distribution by the central limit theorem. That is, we
approximate
(Qik·, Ri1k·, ...., Rinikk·)
T
∣∣Wi ∼ MVN(Aik, Bik), (3.8)
where Aik and Σik are derived from the distribution of Qiks and Rijks based on (3.1)





1 + exp [−bk(tijk − µk − χkWi)]
, and
then Aik = [cik, (1−cik)pi1k, ..., (1−cik)pinikk]T. The covariance Bik has corresponding
terms Var(Qik·) = cik(1 − cik)/Ni, Var(Rijk·) = pijk(1 − cik)(1 − pijk + cikpijk)]/Ni,
cov(Rijk·, Rij′k·) = (1− cik)cikpijkpij′k/Ni, and cov(Rijk·, Qik·) = −pijkcik(1− cik)/Ni.
The component l
(2)
















Note that the only term that contains Wi is pijk. It is convenient to combine this
vector with vik and form the vector Uik = [Qik·, Ri1k·, . . . , Rinikk·, vik]
T as having a
multivariate normal distribution given Wi:









, Σik := σ
2
εk
Inik , in which 1 is a column vector of all 1’s, Inik is
nik × nik identity matrix, and aik = αTi Xk. The likelihood function l
(1)
ik is then rep-
resented as: −1
2
log |Σik| − 12(Cik − EikUik)
TΣ−1ik (Cik − EikUik). Since the density
function of the data and the latent variable is conjugate, it is convenient to directly
derive the posterior distribution of Uik given Yik and Wi, which is still a multivariate
normal distribution:




















The conditional expectation Ê [g1(Qik·, Rijk·, vik)|Wi] can be easily derived from the
posterior mean and posterior covariance of Uik. After turning each expectation into
a function of Wi, we use Gauss-Hermite quadratures to evaluate the integration with
respect to Wi. The numerical integration requires only one-dimensional integral of
Wi, which makes our model computationally easy. The details of computing the
conditional expectations and numerical integration is in Appendix B.2.
The initials of parameters (βk,αk) for each biomarker in the EM algorithm are
obtained from a linear mixed effects model, which assumes cik = 1, bk = 0 and thus
the sigmoidal part does not exist. The convergence criterion is set as the change of
log-likelihood stays within 0.05% of the current step estimated log-likelihood. The
E-step and M-step are iterated until convergence.
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3.3 Simulation Studies
We simulated two biomarkers based on the data generative mechanism with the
number of patients n = 100, 200. We also assessed sensitivity to the choice of Ni
by using constant 100, 104. The simulation is based on the binomial assumption.
The age of visit and CAG were fixed at the observed values of PREDICT-HD data.
The covariate was standardized. We generated 200 bootstrap samples to compute
standard errors. The 95% CIs are calculated by using 2.5% and 97.5% quantiles of the
bootstrap estimates. With initial values and the convergence criterion aforementioned
in Section 3.2, the algorithm converges after about 20-40 iterations.
The true values of parameters, mean and median bias, standard error, and the CP
of the CI are listed in Table 3.1. The result shows that the algorithm is stable and the
estimated parameters are robust under different Ni (changes within 2% for 95% of
the parameters). The parameters of most interest in our application are (bk, µk, χk),
which determine the rate of change of each biomarker and the temporal order among
different biomarkers. For the average inflection point µk, the largest mean bias is
−0.16 year, and the standard deviation (s.d.) decreases from 0.45 to 0.34 year for
the first biomarker and from 0.58 to 0.39 year when the sample size increases from
100 to 200 patients. The estimation of bk is also precise with mean bias less than
1% of the absolute value of the true value. The adequate estimation performance of
(bk, µk, χk) demonstrates that the strategy of translating the optimization to linear
optimization through a latent working model is successful in terms of estimation. The
covariate coefficient αk1, ηk1, k = 1, 2 and θ are also well estimated with small mean
47
and median bias and relatively small standard error.
Table 3.1: Simulation Result of the Two-Biomarker Model based on 200 Bootstrap Samples
marker 1 marker 2
N, n Par True MeanB MedianB s.d. s.e. CP% True MeanB MedianB s.d. s.e. CP%
100, 100 βk -0.1 -0.006 -0.006 0.008 0.009 91 -0.2 -0.002 -0.001 0.017 0.017 93.5
αk0 66 0.114 0.171 0.360 0.363 92.5 56 0.056 0.061 0.494 0.485 94
αk1 -3 0.021 0.018 0.172 0.170 93 -4 0.004 -0.016 0.117 0.132 96.5
ηk0 0.3 0.016 0.015 0.064 0.061 94.5 0.2 0.001 0.008 0.084 0.085 92.5
ηk1 1 0.007 0.007 0.066 0.065 95 2 0.024 0.022 0.090 0.104 96
θ -4 0.190 0.073 0.850 1.065 97 -4 0.190 0.073 0.850 1.065 97
bk -0.2 -0.001 -0.001 0.010 0.009 92.5 -0.3 0.002 0.002 0.016 0.020 96.5
µk 41 -0.045 -0.043 0.449 0.440 95.5 42 -0.164 -0.109 0.575 0.572 96
χk 1 0.021 0.055 0.210 0.188 91 2 0.064 0.070 0.331 0.339 91
σvk 0.63 0.053 0.034 0.134 0.138 93.5 0.66 0.025 0.014 0.127 0.135 95
σεk 0.58 0.021 0.025 0.099 0.097 92 1.15 -0.003 -0.015 0.061 0.062 94.5
ck0 0.57 0.008 0.005 0.015 0.014 94.5 0.55 0.000 0.000 0.020 0.020 93.5
100, 200 βk -0.1 -0.005 -0.006 0.007 0.008 92 -0.2 0.001 0.001 0.012 0.013 93
αk0 66 0.116 0.112 0.233 0.229 94.5 56 -0.012 -0.034 0.348 0.319 93.5
αk1 -3 0.028 0.035 0.117 0.115 93.5 -4 0.003 -0.012 0.084 0.090 96
ηk0 0.3 0.032 0.030 0.052 0.043 91 0.2 0.000 0.002 0.051 0.057 96
ηk1 1 0.001 0.004 0.042 0.042 94 2 0.011 0.008 0.056 0.060 93.5
θ -4 0.043 -0.028 0.496 0.505 97 -4 0.043 -0.026 0.496 0.505 97
bk -0.2 -0.002 -0.003 0.005 0.005 92 -0.3 0.000 -0.001 0.011 0.012 97.5
µk 41 -0.067 -0.079 0.340 0.318 94.5 42 -0.081 -0.023 0.389 0.423 95
χk 1 0.012 0.007 0.112 0.113 92.5 2 0.004 -0.028 0.220 0.217 93.5
σvk 0.63 0.023 0.024 0.081 0.088 97 0.66 -0.007 -0.016 0.072 0.089 95.5
σεk 0.58 0.029 0.032 0.069 0.068 92 1.15 0.001 0.003 0.043 0.040 94
ck0 0.57 0.012 0.007 0.011 0.009 91 0.55 0.000 0.001 0.011 0.012 96
104, 200 βk -0.1 -0.006 -0.006 0.007 0.008 92 -0.2 0.001 0.001 0.013 0.011 92.5
αk0 66 0.116 0.112 0.234 0.228 94 56 -0.011 -0.035 0.349 0.316 94
αk1 -3 0.028 0.035 0.117 0.116 93 -4 0.003 -0.011 0.083 0.091 98
ηk0 0.3 0.032 0.031 0.050 0.042 91 0.2 0.000 0.002 0.052 0.057 96
ηk1 1 0.001 0.004 0.040 0.038 93.5 2 0.011 0.008 0.056 0.060 94
θ -4 0.043 -0.028 0.497 0.506 96.5 -4 0.043 -0.028 0.497 0.506 96.5
bk -0.2 -0.002 -0.003 0.006 0.006 90.5 -0.3 0.000 -0.001 0.011 0.012 98
µk 41 -0.067 -0.080 0.339 0.317 94 42 -0.080 -0.023 0.388 0.424 97.5
χk 1 0.012 0.007 0.112 0.114 92.5 2 0.004 -0.029 0.223 0.220 94
σvk 0.63 0.025 0.027 0.081 0.087 97 0.66 -0.007 -0.014 0.072 0.087 98
σεk 0.58 0.029 0.032 0.069 0.068 92 1.15 0.001 0.003 0.043 0.040 94
ck0 0.57 0.012 0.007 0.011 0.009 91 0.55 0.000 0.001 0.012 0.014 95
∗: In the table, N represents the number of neuron ensembles simulated, and n is the number of patients simulated. We listed
the results for the three different settings of N,n. The true parameters are listed in the column “True”. The column “MeanB”
and “MedianB” is the mean and median bias of estimate from the truth. For the kth biomarker, βk is the coefficient of linear
trend of time; αk is the coefficient vector of covariates in estimating the scale parameter ak; ηk is the coefficient vector of
covariates in estimating logit−1(ck), where ck is the CR parameter; µk is the mean inflection point of the sigmoid curve for
an average subject with mean covariates, χk is the scale parameter for the latent variable Wi; σvk and σεk are the standard
deviation of the random effect and measurement error, respectively; and θ is the shared coefficient vector of covariates in
estimating Wi across biomarkers.
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3.4 Application to PREDICT-HD Data (Revisit)
Same as the previous chapter, we applied the model to PREDICT-HD data. The
main interest is in estimating the effect of CAG repeat length on the inflection points
and CR parameters of several neuroimaging measures, and assessing their temporal
order of degeneration.
The four regions of interest are critical areas related to pathological progression
and clinical symptoms of HD: caudate and putamen (in the striatum) are the main
components of the base of brain that control muscle-driven movements of the body,
or “motor movement”; emerging evidence from animal models of HD suggests that
some of the early cognitive deficits may have a hippocampal basis (Duyao et al., 1993);
thalamic degeneration contributes to the impairment of executive function in early
HD (Kassubek et al., 2005). Neuronal loss in striatum is mainly related to motor
function and neuron loss in thalamus is more associated with cognitive impairment
and poor performance in executive tests. However, there is little knowledge about
when, during the course of HD, thalamic degeneration sets in compared with caudate
and putamen. Thus, it is important to determine the progression of atrophy of each
area to understand the occurrence of motor dysfunction and cognitive dysfunction.
We applied our model to the four biomarkers using three covariates: CAG repeat
length, gender, and DCL. All three covariates were measured at baseline and stan-
dardized. We conducted the estimation separately with three choices of Ni : 100, 10
4,
and a subject-specific number proportional to intracranial-corrected volume (ICV)
with a range 37 to 62. The result shows that the algorithm is stable and the esti-
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mated parameters are robust under different Ni. The CIs of the biomarker trajectories
were calculated based on 2.5% and 97.5% quantiles of the estimates from bootstrap
samples.
Figure 3.2 shows the estimated mean trajectory, E(Y |Z = 0,W = 0), the 95%
CI, and observed data from 100 patients. The CIs for hippocampus and thalamus
are relatively wider. The results in Table 3.2 show that the linear trend βk is almost
negligible for each biomarker and therefore each biomarker is primarily dominated
by a sigmoidal component. The effect of CAG on the CR parameter cik = η
T
kXi
is relatively stronger in caudate and putamen: with 1 s.d. increment of CAG, c
decreases to 0.49c for caudate and 0.48c for putamen. For an average patient, the
CR parameter is around 0.30 (s.d. = 0.009) for putamen, 0.19 (s.d. = 0.007) for
caudate, 0.47 (s.d. = 0.007) for hippocampus and 0.62 (s.d. = 0.006) for thalamus.
This can be viewed as the percentage of normal functioning neurons at the end-
stage of HD. The higher CR parameter for hippocampus and thalamus shows that
neuronal dysfunction is less severe compared with that of caudate and putamen. This
is relatively consistent with previously reported findings of HD patients, showing that
adjacent non-striatal regions, such as the thalamus, remain mostly intact (Vonsattel
et al., 1985), and atrophy of the hippocampus is around 35% at the end stage of HD



























































Figure 3.2: The four neuroimaging biomarkers with data of 100 patients exhibited (colored
longitudinal trajectories). The black line is the estimated mean level E(Y |X = 0,W = 0)
with linear slope and sigmoid curve, and the bootstrap confidence band is overlaid in grey.
Our results show a significant effect of CAG repeat length on the latent liability
score E(Wi) = θ
TZi, which is the shared component in the inflection points dik across
the four biomarkers. By the relation dik = χkWi + µk, the effect of CAG repeats on
inflection point dik is further amplified for caudate and putamen, with χ = 7.2 and
8.8, compared with χ = 5.6 and 5.9 for hippocampus and thalamus. Therefore, in
patients with 2 more CAG repeats, the inflection point shifts backward by 4.97 years
for putamen and 6.07 years for caudate, on average. The relatively large value of
χ implies a greater biological variability of the distribution of the inflection points
for putamen and caudate compared with hippocampus, and thalamus. Figure 3.3
51
shows the probability of the normal status, P (Bijks = 1), for a patient with CAG
= 40, 42, 44, 46 and other covariates at the mean level. As CAG repeats length
increases, the curves move towards an earlier inflection point age and decrease to
a lower level. Caudate and putamen are further separated from hippocampus and
thalamus.
Figure 3.3: Estimated P (Bijks = 1|CAG = 40, 42, 44, 46) for subpopulations in PREDICT-
HD data with CAG = 40 (upper left), CAG = 42 (upper right), CAG = 44 (bottom left)
and CAG = 46 (bottom right) with other covariates fixed at the sample mean.
The age at the inflection point for a patient with score Wi = 0 is 38.0, 42.4, 45.0
and 51.8 years for caudate, putamen, hippocampus, and thalamus. (Aylward et al.,
2004) found that the time when caudate area atrophy becomes significantly different
from that of control patients was about 2 years earlier than that of putamen. Our
estimation of the order of the progression of putamen and caudate is consistent with
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(ibid.), while our estimation of the time gap is larger. This is because we used the
inflection point of each sigmoid curve as an anchoring event rather than the gap at
the early stage when each curve starts to decline. The average inflection point of the
thalamus is about 10 years later than that of caudate and putamen, which validates
the observation that neuronal loss within thalamus may occur in the end-stage HD
patients at autopsy (Vonsattel et al., 1985).
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Table 3.2: Parameter Estimates of the Four Neuroimaging Biomarkers from PREDICT-HD
Data
N Par Cov Putamen s.d. Caudate s.d. Hippo s.d. Thalamus s.d.
N=100 βk -0.004 0.001 -0.012 0.007 -0.007 0.002 -0.004 0.004
αk0 71.801 0.095 72.097 0.610 29.945 0.094 114.355 0.231
αk1 CAG 0.066 0.044 0.490 0.246 -0.295 0.022 -0.058 0.054
αk2 gender -0.604 0.023 -0.916 0.189 -0.280 0.010 -0.492 0.020
αk3 DCL -0.356 0.032 -1.531 0.237 -0.294 0.010 -0.015 0.027
ηk0 -0.860 0.042 -1.482 0.049 -0.106 0.029 0.489 0.026
ηk1 CAG -0.710 0.077 -0.728 0.092 -0.022 0.042 0.012 0.043
ηk2 gender -0.059 0.059 -0.038 0.075 -0.044 0.043 -0.042 0.033
ηk3 DCL -0.117 0.063 -0.211 0.083 -0.001 0.045 -0.050 0.034
θ1 CAG -0.689 0.159 -0.689 0.159 -0.689 0.159 -0.689 0.159
θ2 gender -0.058 0.115 -0.058 0.115 -0.058 0.115 -0.058 0.115
θ3 DCL -0.114 0.128 -0.114 0.128 -0.114 0.128 -0.114 0.128
bk -0.073 0.003 -0.053 0.003 -0.063 0.003 -0.057 0.003
µk 42.447 0.362 37.962 0.563 45.009 0.598 51.818 0.776
χk 7.225 0.559 8.794 0.643 5.650 1.245 5.906 1.539
σvk 2.332 0.412 2.814 0.549 2.004 0.148 4.572 0.325
σεk 1.971 0.106 3.143 0.141 0.919 0.055 2.856 0.180
ck 0.299 0.009 0.185 0.007 0.473 0.007 0.620 0.006
N = 104 βk -0.004 0.001 -0.011 0.007 -0.007 0.002 -0.004 0.004
αk0 71.779 0.098 72.075 0.599 30.019 0.100 114.417 0.241
αk1 CAG 0.062 0.048 0.488 0.221 -0.289 0.025 -0.055 0.050
αk2 gender -0.611 0.029 -0.922 0.178 -0.278 0.008 -0.497 0.034
αk3 DCL -0.349 0.031 -1.539 0.190 -0.303 0.010 -0.015 0.026
ηk0 -0.852 0.041 -1.485 0.051 -0.107 0.028 0.486 0.022
ηk1 CAG -0.714 0.079 -0.723 0.087 -0.022 0.039 0.013 0.041
ηk2 gender -0.057 0.058 -0.038 0.081 -0.039 0.046 -0.043 0.031
ηk3 DCL -0.113 0.061 -0.212 0.084 -0.001 0.044 -0.042 0.030
θ1 CAG -0.683 0.132 -0.683 0.132 -0.683 0.132 -0.683 0.132
θ2 gender -0.060 0.120 -0.060 0.120 -0.060 0.120 -0.060 0.120
θ3 DCL -0.114 0.126 -0.114 0.126 -0.114 0.126 -0.114 0.126
bk -0.072 0.003 -0.053 0.004 -0.064 0.002 -0.057 0.003
µk 42.451 0.384 37.991 0.550 45.045 0.702 51.800 0.686
χk 7.240 0.566 8.751 0.712 5.611 1.298 5.917 1.602
σvk 2.354 0.672 2.840 0.609 1.989 0.133 4.591 0.341
σεk 1.973 0.099 3.148 0.145 0.920 0.052 2.858 0.183
ck 0.298 0.008 0.185 0.006 0.473 0.006 0.619 0.006
N ∝ to ICV βk -0.004 0.001 -0.012 0.006 -0.007 0.003 -0.006 0.006
αk0 71.781 0.111 72.041 0.559 30.001 0.090 114.015 0.253
αk1 CAG 0.009 0.019 0.421 0.217 -0.219 0.024 -0.049 0.060
αk2 gender -0.598 0.031 -0.931 0.171 -0.281 0.015 -0.450 0.026
αk3 DCL -0.351 0.029 -1.500 0.258 -0.266 0.021 -0.014 0.020
ηk0 -0.848 0.050 -1.495 0.0694 -0.105 0.025 0.491 0.030
ηk1 CAG -0.612 0.067 -0.711 0.112 -0.021 0.042 0.015 0.049
ηk2 gender -0.066 0.063 -0.013 0.066 -0.051 0.039 -0.049 0.032
ηk3 DCL -0.129 0.060 -0.220 0.090 -0.004 0.050 -0.044 0.029
θ1 CAG -0.683 0.161 -0.683 0.161 -0.683 0.161 -0.683 0.161
θ2 gender -0.052 0.118 -0.052 0.118 -0.052 0.118 -0.052 0.118
θ3 DCL -0.115 0.130 -0.115 0.130 -0.115 0.130 -0.115 0.130
bk -0.072 0.004 -0.055 0.003 -0.063 0.004 -0.057 0.005
µk 42.412 0.400 38.007 0.581 45.001 0.555 51.791 0.703
χk 7.242 0.602 8.780 0.659 5.619 1.222 5.911 1.524
σvk 2.311 0.432 2.786 0.532 2.022 0.147 4.611 0.320
σεk 1.970 0.102 3.142 0.139 0.917 0.050 2.854 0.182
ck 0.299 0.009 0.183 0.007 0.474 0.007 0.620 0.007
∗: In the table, N is the number of neuron ensembles assumed. For the kth biomarker, βk is the coefficient of
linear trend of time; αk is the coefficient vector of covariates in estimating the scale parameter ak; ηk is the
coefficient vector of covariates in estimating logit−1(ck), where ck is the CR parameter; µk is the mean inflection
point of the sigmoid curve for an average subject with mean covariates, χk is the scale parameter for the latent
variable Wi; σvk and σεk are the standard deviation of the random effect and measurement error, respectively;
and θ is the shared coefficient vector of covariates in estimating Wi across biomarkers.54
We compared the prediction performance of our method with other methods in-
cluding linear mixed effects model (LME), nonlinear mixed effects model (NLME)
and generalized additive model (GAM) in Table 2. We used cross-validation to im-
plement methods on 90% (i.e., 195 subjects) of data and performed prediction on 10%
of the data (i.e., 22 testing subjects). The process was repeated 100 times. The LME
model contains the same covariates as our model. The NLME with sigmoid mean
function aik(cik + 1− cik/(1 + exp(−bk(t− dik))) and subject-level random effects in
dik incurred convergence issues in many cases. Our method outperformed the best
alternative method (GAM) by a 10% decrease of the prediction error. In addition,
our method can be used to predict dynamic changes of biomarkers and inflection
points for a new patient based on his or her baseline measures. An online application
is designed and can be found in Appendix B.3.
In summary, the putamen and caudate regions start to atrophy at a much earlier
age and have a greater percentage change between the early stage and end stage
of HD compared with hippocampus and thalamus, while the latter biomarkers have
rates of change more similar. The effect of CAG repeats and initial diagnosis is larger
for the putamen and caudate regions.
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Table 3.3: Mean Square Error (MSE) of Testing on 10% Out-of-Sample Data Based on 100
Sampling Data
Evaluation LME NLME GAM Our model
Mean of out-sample
√
MSE 3.512 14.992 3.451 3.202
S.d. of out-sample
√
MSE 0.331 0.408 0.349 0.311
The estimated MSE is based on 10% testing data by fitting linear mixed
effect model (LME), nonlinear mixed effect model (NLME), generalized
additive model (GAM) and our model on 90% training data. The proce-
dure is repeated 100 times with randomly sampled data. LME uses the
same three covariates as our model. NLME uses the same three covariates
in estimating a, c, d in the functional form a(c+(1−c)/(1+exp(−b(t−d))).
GAM is fitted using cubic spline basis of age and the same three covariates.
3.5 Discussion
In this chapter, we propose a biologically meaningful, latent variables model to in-
tegrate biomarkers that indicate pathological changes of neurodegenerative disorders
to predict disease progression. The model formulates the observed biomarker values
as a manifestation of mean activity of latent states of neural ensembles. The latent
states coincide with the concept of CR. The resulting marginal model of the observed
biomarkers takes a nonlinear form that is consistent with the existing literature. The
latent inflection point of each biomarker is linked to a common liability score mod-
eled by covariates associated with a patient’s genomic features and baseline measures.
The model integrates biomarkers measured on heterogeneous scales by mapping them
onto a common scale to allow comparisons across biomarkers and subjects. Corre-
sponding to the “linearization” of a model for nonlinear data, an EM algorithm is
proposed to solve a difficult optimization with several explicit solutions in the M-step
and a one-dimensional numeric integration in the E-step.
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Extension of our method to handle discrete outcomes can be achieved by assuming
a cumulative logistic distribution with random inflection points. Another extension is
to jointly model time-to-disease-diagnosis, biomarkers, and clinical signs. When the
number of biomarkers is high, some regularization needs to be placed on bk and χk,
and performing variable selection is desirable for choosing biomarkers informative of
the latent liability score Wi.
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Chapter 4
A Semiparametric Model for Nonlinear Dynamical System
4.1 Outline
In this chapter, Section 4.2 introduces the framework of modeling nonlinear ODE
systems using semiparametric multi-index models. In Section 4.3, the consistency of
the nonparametric link function of IIM-ODE and the semiparametric efficiency of the
estimators for βk are proved, and their asymptotic distribution is derived. In Sec-
tion 4.4, we performed extensive simulations to examine finite sample performance
of the estimation and inference procedure, as well as the variable selection perfor-
mance when the number of biomarkers is large. IIM-ODE shows better performance
on the DREAM challenge simulated gene expression data compared to an existing
approach. In Section 4.5, we applied IIM-ODE to an EEG study of patients with




Consider p biomarkers from subject i, denoted by Mi(t) = (Mi1(t), . . . ,Mip(t))
T,
and let Xi denote the q-dimensional covariates for this subject. We assume that the
biomarkers satisfy the following ODEs




kXi), k = 1, . . . , p, t ∈ [0, T ], (4.1)
where T is the study duration, fk is an unknown link function, and βk and αk are the
indices corresponding to the biomarkers and the covariates, respectively. The initial
condition Mi(0) comes from a non-degenerate distribution with bounded support.
For identifiability, we require βk to have norm one and the kth component to be
positive. Similarly, we assume αk to have a unit norm and the first component
to be positive. We note that the initial condition of the ODE system represents
the randomness due to subject/experiment uncertainty. As a special case, when all
subjects are homogeneous, i.e., Xi is empty, we remove the second index, and the
above model reduces to a single-index ODE system.
Suppose that the biomarkers are measured at discrete time points t1 = 0, . . . , tN
with measurement errors. Let Yijk denote the measurement of the kth biomarker at
tj for subject i. We assume that the measurement process is
Yik(t) = Mik(t) + εik(t), (4.2)
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where εik(t) is a white noise process with mean zero. We denote Yijk = Yik(tj). Corre-
lation structure for εik(t), k = 1, . . . , p can be introduced to allow spatial correlation.
Estimation
We propose the following method, referred to as Integrated Index Model for Ordinary
Differential Equations (IIM-ODE), for estimation. Since (4.1) implies














kXi)ds. First, we obtain an initial kernel estimator for Mik(t)














where K(·) is a symmetric kernel function and aN is the bandwidth. The choice of
K(·) can be either a Gaussian kernel or Epanichkov kernel and aN is of order N−1/5.























To this end, we approximate fk by the tensor product of Kn B-spline basis func-
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tions of order m with Kn − m2 interior knots in a bounded interval containing
the support of βTk M̂i(t) and α
T
kXi. We denote the tensor basis functions by












where Mn is a large constant to be chosen of order logKn. With this spline basis




















which is quadratic in θk but nonlinear in βk,αk.
To estimate θk, βk and αk, we adopt a two-step iterative algorithm. In the first
step, given the current estimate of β̂k and α̂k, we obtain the basis coefficients of the
link function by computing














































at the current estimate of β̂k and α̂k using the first-order Taylor expansion, we obtain






































in which B′l is the derivative of the spline basis functions with respect to the lth
argument for l = 1, 2. Clearly, the above approximation can be easily minimized,
yielding the updated values for βk and αk. We iterate between these two steps until
convergence.
To choose the number of the knots, we use Bayesian information criterion (BIC).


















+ (R +Kn) log nN,(4.7)
where R is the total number of βk, k = 1, . . . , p.
Remark 1. An alternative approach is to first obtain the estimated derivatives of
Mi(t) and then perform the least squares estimation between the estimated deriva-
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tives and the right-hand side of (4.1). IIM-ODE does not require the estimation of
the derivatives which can be highly variable; instead, it uses the integral equation
of (4.1) that leads to more efficient estimation. We will further demonstrate this
appealing property in subsequent numerical studies.
Sparse Network Estimation
To avoid overfitting and obtain a sparse network in the presence of a large number
of the biomarkers, we impose sparsity regularization in the estimation, for example,
by introducing LASSO penalty (Friedman, Hastie, and Tibshirani, 2010) to (4.4) for



















+ λk ‖βk‖1 , k = 1, . . . , p,
where λk is a non-negative sparsity-inducing tuning parameter that controls the L1-
norm of the parameters βk. The computation is similar to before except that in the
step to update βk, we perform a penalized regression in the least-square estimation
for (4.6). The tuning parameter λk is selected by the BIC in (4.7), where R is the
total number of non-null βk. The final network defined by the sparse vectors βk, when
applied to neural dynamics, represents the influence that one neural system exerts
over the change rate of another, and thereby quantifies the effective connectivity
(Friston, Harrison, and Penny, 2003).
We summarize the estimation procedure in Algorithm 1 below.
Remark 2. When there are no covariatesXi in model (4.1), i.e., the ODE is a single-
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Algorithm 1
1: For each k, initialize βk to be a vector of (. . . , 1, . . . )
T, in which 1 is set for the
best marginal predictor; initialize αk as some a vector of L1-norm of one.
2: for λk decreases at a grid (λs), s = 1, . . . , S from a large value to 0 do
3: while the objective function decreases significantly do
4: Given βk,αk, update θk by minimizing (4.5) for each k.
5: Given θk, update βk,αk based on (4.6) for each k.
6: Scale βk,αk, k = 1, . . . , p to have L1−norm of one.
7: return βk,αk and θk for each k and record the BIC
(λs).
8: return βk,αk and θk that have the smallest BIC.
index model M ′ik(t) = fk(β
T
kMi(t)), k = 1, · · · , p, the same estimation algorithm can
be used. The only difference is that fk is approximated by the spline basis functions
in a one-dimensional real space.
4.3 Asymptotic Properties
We provide the asymptotic properties for β̂k and α̂k given in Section 4.2. First, we
need the following conditions for model identifiability:
(C.1) Covariance matrix of X is non-singular, and the support of X is open and
convex with at least one interior point.
(C.2) Let D denote the union of the support for (βTkM (t),αTkX) over (βk,αk) and
t ∈ [0, T ]. We assume that fk(·, ·) is continuous in D.
(C.3) For the measurement time points, it holds maxj{|tj − tj−1|} = O(N−1) and
aN → 0, NaN →∞. Furthermore, n2/(NaN log a−1N ) = O(1).
Then the following lemma holds.
Lemma 1. Under (C.1)-(C.3), the parameters and function in model (4.1) are iden-
tifiable.
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Next, we establish the asymptotic properties of the estimators for βk and αk
including consistency, convergence rates, and asymptotic normality. To this end, we
need the following additional conditions:
(C.4) The true link function for fk, denoted by fk0, has bounded (d+ 2)
th derivative
in an open set containing D where d > 13.
(C.5) Kn →∞, K13n n−1/2 → 0 and n1/2K−dn → 0.
Under these conditions, we first obtain the consistency and the convergence rate
of the estimators.
Theorem 1. Under conditions (C.1)-(C.5), it holds that for k = 1, ..., p, β̂k → βk0
and α̂→ αk0 in probability. Furthermore, for k = 1, ..., p,
∥∥∥β̂k − βk0∥∥∥2 + ‖α̂k −αk0‖2 + ∥∥∥f̂k − fk0∥∥∥2
L2(D))
≤ op(n−1/2) +Op(K−dn ). (4.8)
Theorem 2. Under conditions (C.1)-(C.5),
√
n(β̂k−βk0, α̂k−αk0)pk=1 converges in
distribution to a multivariate normal distribution with mean zeros.
The detailed proofs are given in Appendix C. The above theorems establish both
consistency and asymptotic normality, which facilitate inference of the network con-
nectivity parameters βk. The asymptotic covariance for β̂k and α̂k depends on some
functions solving an implicit integral equation, which requires intensive numerical
computation to obtain solutions. Instead, we use bootstrap to estimate the asymp-




We simulated data under two settings, a low-dimension setting (p = 4) that focuses
on estimation and inference of the network parameters, and a moderate-dimension
setting (p = 40, with 1, 600 potential connections) that focuses on identifying the
network structure. For each setting, we simulated four scenarios under different
sample size n and time points N (i.e., (n,N) = (50, 20), (50, 40), (100, 20), (200, 5)).
Two covariates X are generated independently from uniform distribution U(−1, 1).
Time points are randomly sampled from [0, 1]. The true link function, f(u, v) =
u(1− u)v, is a quadratic form of the first index score and a linear form of the second
index. The underlying ODE for two settings are
M ′ik(tj) = β
T
kMi(tj)(1− βTkMi(tj))αTkXi,
Yijk = Mi(tj) + εijk, i = 1, . . . , n, j = 1, . . . , N, k = 1, . . . , p.
Here αk and βk are vectors standardized with norm one. The true values of αk and βk
are presented in Table 4.1. The initial conditions (Mi1(0), . . . ,Mip(0))
T are sampled
from truncated normal distribution N(0, 0.12Ip)
⋂
[−1, 1]. The standard deviation of
Gaussian error is σ = .05 for the low-dimensional setting and 0.01 for the moderate-
dimensional setting. For each setting, the number of repetitions is 100.
We measure the goodness-of-fit of the estimated network parameters β̂k and co-
variate parameters α̂k by the absolute inner products between the true parameter
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Table 4.1: Parameter Estimation of the Low-Dimensional Simulation Setting of p = 4, n =
100 and N = 20
Parameter True Mean s.d. s.e. CP% Parameter True Mean s.d. s.e. CP%
α11 0.600 0.600 0.059 0.086 96 α31 0.447 0.447 0.062 0.095 97
α12 0.800 0.796 0.045 0.128 96 α32 -0.894 -0.892 0.031 0.155 97
β11 0.333 0.327 0.094 0.106 95 β31 -0.333 -0.325 0.068 0.100 95
β12 -0.667 -0.652 0.060 0.182 95 β32 0.000 -0.002 0.067 0.113 98
β13 0.000 -0.006 0.078 0.132 99 β33 0.667 0.666 0.058 0.166 98
β14 0.667 0.668 0.061 0.184 95 β34 0.667 0.660 0.059 0.168 95
α21 -0.707 -0.705 0.050 0.081 96 α41 -0.894 -0.890 0.038 0.074 97
α22 0.707 0.705 0.052 0.161 96 α42 -0.447 -0.448 0.074 0.146 98
β21 0.500 0.487 0.074 0.107 95 β41 0.333 0.331 0.088 0.102 93
β22 0.500 0.501 0.069 0.151 95 β42 0.000 -0.010 0.158 0.114 95
β23 -0.500 -0.506 0.065 0.164 97 β43 0.667 0.644 0.101 0.174 94
β24 0.500 0.487 0.070 0.156 92 β44 -0.667 -0.651 0.101 0.166 95
Under simulation setting of 100 patients and 20 time points each, we simulated 100 datasets, and for each dataset, we
generated 100 bootstrap samples by random sampling patients. The column “mean” and “s.d.” are the mean and standard
deviation of the 100 estimates over the 100 datasets. The column “s.e.” is the average of standard deviations calculated
using bootstrap samples. The column “CP%” is the coverage probability of the real parameter by using 2.5% and 97.5%
quantile of bootstrap estimates from 100 datasets.
and the estimated parameter |βTk β̂k| and |αTk α̂k| (a value of one suggests perfect
fit). We evaluate the performance of estimating the functional form fk by the mean










|f̂k(uijk, vik)− fk(uijk, vik)|, (4.9)
in which uijk = β
T
kMi(tij), vik = α
T
kXi are the true index scores.
The simulations results are summarized in Figure 4.1 and Figure 4.2. Figure 4.1
shows a high precision of parameter estimation in almost every setting with the inner
product in the range of [0.95, 1], other than some outliers. The performance of param-
eter estimation is improved as the number of systems/subjects increases, and as the
number of time points increases. Comparing n = 50, N = 40 and n = 100, N = 20,
each with 2, 000 observations, a larger sample size of systems/subjects has a greater
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Figure 4.1: The absolute inner product |βTk β̂k| and |αTk α̂k| for four low-dimensional datasets
with p = 4.
Figure 4.2: The standard deviation of f(u, v) on true indices and the MAD error defined
as (4.9).
impact on improving the estimation accuracy. The left panel of Figure 4.2 shows the
standard deviation of fk(uijk, vik) is around 0.04 whereas the right panel shows the
small magnitude of MAD error at the true index scores. We further evaluated the
bias, standard deviation of the estimates and the CP under n = 100, N = 100 based
on 100 simulation datasets, each with 100 bootstrap samples. We used the 2.5% and
97.5% quantile of the bootstrap estimates to generate the CIs of βk and αk. The
mean and the standard deviation (s.d.) of the estimates from 100 simulation datasets,
the mean of the standard deviation of the bootstrap samples (s.e.) and the CP are
listed in Table 4.1. The results show a low bias and the CP is close to 95%.
Next, we consider the same generating model but increase the number of biomark-
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Figure 4.3: The TPR, FPR of identifying non-null βk, k = 1, . . . , 40; the mean square error
of the estimated parameters including βk,αk, k = 1, . . . , 40 (bottom left); the area under
ROC curve (bottom right).
ers to p = 40 with 200 non-null parameters among 1,600 parameters for the first index
score. Fig 4.3 shows that the recovery of a relatively sparse network is adequate for
almost every setting, with true positive rate (TPR) (upper left) higher than 0.8 and
false positive rate (FPR) (upper left) lower than 0.2. The mean squared error of the
initials of the βk starts from 0.02 and eventually decreases to 0.001− 0.004 (Fig 4.3
bottom left). The area under the receiver operative characteristic curve (AUC) is
higher than 0.9 in all settings. Overall, with the same number of observations, the
performance of a larger number of systems/subjects with sparser time points is better
than a smaller number of systems/subjects but with denser time points. The setting
n = 200, N = 5 works surprisingly well, suggesting that our method is applicable to
longitudinal studies with sparse visits.
The computational burden of IIM-ODE is low. For the low-dimensional setting,
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the convergence reached after about 20 iterations, and for the moderate-dimensional
setting, the convergence reached after about 50 iterations.
DREAM Challenge Simulated Gene Expression Data
In the second set of simulations, we applied IIM-ODE to in silico gene expression
data generated externally by GeneNetWeaver (GNW) in the third DREAM chal-
lenge (Marbach et al., 2009). GNW extracts sub-networks from the yeast or E. coli
gene regulatory networks and assigns a system of ODEs to the extracted network.
The dynamic model simulates both transcription and translation derivative using
a standard thermodynamic approach (Ackers, Johnson, and Shea, 1982), which al-
lows for both independent (“additive”) and synergistic (“multiplicative”) regulatory
interactions.
We compare our method with GRADE proposed in Chen, Shojaie, and Witten,
2016, which assumes an additive model M ′j(t) = βj0 +
∑p
k fjk(Mk(t)) by using cubic
splines with two internal knots as the basis functions in modeling fjk. We investigate
ten networks from GNW that have been previously studied in ibid., of which five
have 10 nodes, and five have 100 nodes. For each network, GNW provides one set
of noiseless gene expression data consisting of R perturbation experiments where the
trajectories are measured at 21 evenly spaced time points in [0, 100]. Here N = 10
for the five 10-node networks and N = 100 for the five 100-node networks. As in
ibid., we added independent N(0, 0.025) measurement errors to the data at each time
point. IIM-ODE uses quadratic splines with one internal knot for each fk as the basis
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functions, and uses N independent experiments to select the spline basis function for
fk. For each experiment setting, we calculated the AUC for correctly identifying
the active edges. The confidence interval for the AUC of IIM-ODE is obtained by
bootstrapping across the R perturbation experiments.
From Table 4.2, we see a significant improvement of AUC for IIM-ODE in most
cases. In particular, IIM-ODE outperforms the additive models with more parsimo-
nious parameterization, which indicates that the interaction between regulators in
the ODE equations is non-negligible. Besides, our model setting is closer to GNW’s
generative mechanism for multifactorial time series data, which includes perturbation
at the initial condition (i.e., observations at t = 0) for each experiment by increasing
or decreasing the basal activation of all genes of the network simultaneously with a
different random amount. These advantages may have contributed to the improved
AUC of IIM-ODE.
Table 4.2: Area under the ROC Curve (AUC) of GRADE Method and IIM-ODE for Dream
Three Challenge Data
AUC p = 10 p = 100
Dataset GRADE IIM-ODE GRADE IIM-ODE
Yeast1 0.679 (0.666, 0.691) 0.707 (0.692, 0.719) 0.636 (0.635, 0.638) 0.678 (0.672, 0.685)
Yeast2 0.607 (0.600, 0.613) 0.655 (0.649, 0.663) 0.584 (0.582, 0.585) 0.602 (0.590, 0.623)
Yeast3 0.576 (0.566, 0.587) 0.612 (0.593, 0.620) 0.567 (0.566, 0.568) 0.583 (0.575, 0.591)
Ecoli1 0.545 (0.534, 0.557) 0.533 (0.527, 0.536) 0.670 (0.667, 0.673) 0.639 (0.631, 0.648)
Ecoli2 0.643 (0.634, 0.653) 0.661 (0.658, 0.669) 0.653 (0.650, 0.656) 0.671 (0.663, 0.682)
The average area under the curves and 90% confidence intervals, over 100 simulated data sets.
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4.5 Application to the EEG Study of Alcoholism
We applied IIM-ODE to the EEG data collected from a study of brain activity for
alcoholism (Zhang et al., 1995) under different visual stimulations. In this study,
EEG data were collected from 30 alcoholics and 30 control subjects. Within each
group, three visual stimuli (showing a single image, showing two matching images,
showing two non-matching images). The EEG signals were measured from 64 regions
across scalp of multiple subjects at 256 Hz (3.9ms epoch) within one second. The
signal was recorded using the montage with the position at center scalp CZ as the
reference electrode. The 64 regions consist of 61 electrodes placed on the scalp and
3 electrodes placed at the nose and both ears. The 61 electrodes correspond to five
general regions: frontal (prefrontal, left frontal, frontal, right frontal), central (left
central, central, right central), parietal (left parietal, parietal, right parietal), occipital
and temporal (left temporal, right temporal). Figure 4.4 shows the anatomy of these
regions and electrodes within each region.
Figure 4.4: Anatomy of electrodes on brain scalp
These EEG signals can be modeled by an ODE system where different regions in-
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Figure 4.5: The semiparametric function estimated for five positions.
teract to respond to the stimuli. We use IIM-ODE to explore the difference of brain
effective connectivity evoked by different stimuli between healthy control subjects
and alcoholic subjects. Expecting different network structures for each group and
stimulus, IIM-ODE is applied separately to the six cohorts. For each subject, data
were averaged over ten trials under the same stimulus to reduce the random noises,
and the training data were randomly sampled at 128 time points from t ∈ [0, 1]. We
started with a linear function for estimating nonparametric function fk and used BIC
to select the order of splines and number of knots. There was no significant improve-
ment with more knots, and a quadratic function was the best fit. The estimated
functions for five positions are shown in Figure 4.5. In the control group, under
the non-matching image stimulus, the functions are quite linear. There is strong
quadratic effect in the functions for every group other than the control group with
non-matching pictures, and thereby a strong interaction between the biomarkers in
affecting the target biomarker.
For the control group, under the single image paradigm with the matching and
73
non-matching stimuli, the final networks selected by BIC have 853, 621 and 810 edges
whereas for the alcoholic group, the final networks have 802, 544 and 788 edges,
respectively. To determine the effect of Mij on M
′
ik, we take derivative of M
′
ik with








in which f ′k is the derivative of the univariate function fk. To evaluate the overall











The regulatory function depends on time, however, the fitted result under the
quadratic spline is approximately time-invariant. Therefore, we took an average over
all time points and obtained the overall regulatory power Sj of the jth channel. When
the jth channel has a small regulatory effect over all channels, this quantity is close
to zero, and when all channels are independently changing, the sum of regulatory
power over all p = 64 channels is close to zero.
The top 10 signal channels for the six subgroups are presented in Table 4.3 and
the total regulatory power from eight brain regions is presented in Table 4.4. Overall,
the regulatory power is more concentrated at several regions for controls under each
paradigm whereas for alcoholic subjects the network is distributed sparsely over the
whole scalp with the weight of edges, i.e., |βjk|, closer to zero. For the control group
74
subjects, the signal is stronger near the left inferior temporal cortex for all three
paradigms, which is one of the higher levels of the ventral stream of visual process-
ing, associated with the representation of complex object features (Ranganath et al.,
2004). Alcoholic subjects tend to have lower total regulatory power than healthy
controls.
Table 4.3: The Top 10 Channels with Highest Regulatory Power
Alcoholic Control
Top 10 Single Matching Non-matching Single Matching Non-matching
Rank Position Signal Position Signal Position Signal Position Signal Position Signal Position Signal
1 FT8 0.1534 CZ 0.2815 CZ 0.1890 POZ 0.1975 AF7 0.6283 P4 0.3333
2 PO1 0.1529 C6 0.2065 AF7 0.1625 T7 0.1908 CZ 0.3890 PO8 0.2601
3 AF1 0.1491 FC1 0.1705 F2 0.1594 TP8 0.1658 AF8 0.3056 CZ 0.2419
4 P7 0.1360 FCZ 0.1697 F6 0.1503 C3 0.1571 FPZ 0.2707 O1 0.1539
5 P4 0.0961 P4 0.1696 FC2 0.1193 CP5 0.1414 TP7 0.2545 FT7 0.1507
6 FP2 0.0957 CPZ 0.1684 C2 0.1185 C5 0.1378 C1 0.2442 C4 0.1467
7 P3 0.0949 PO7 0.1557 F8 0.1170 F1 0.1360 FC1 0.2180 CP6 0.1431
8 FC4 0.0945 C2 0.1390 CPZ 0.1153 F7 0.1353 CPZ 0.2077 FC3 0.1369
9 FC6 0.0901 F5 0.1319 AF8 0.0997 O1 0.1342 F3 0.1761 C3 0.1231
10 PO8 0.0870 PO3 0.1204 P6 0.0994 PZ 0.1329 O1 0.1751 C1 0.1229
The regions where the channels are located: frontal region (with subregions: prefrontal( FPZ, FP1, FP2, AFZ), left frontal (AF7, AF3, F7, F5,
F3), frontal (F1, FZ, F2), right frontal (AF4, AF5, F4, F6, F8)), central region ( with subregions: left central (FC5, FC3, C5, C3, CP5, CP3),
central (FC1, FCZ, FC2, C1, CZ, C2, CP1, CPZ, CP2), right central (FC4, FC6, C4, C6, CP4, CP6), parietal region (with subregions: left parietal
(P7, P5, P3, PO7, PO3), parietal region (P1, PZ, P2), right parietal region (P4, P6, P8, PO4, PO8), occipital region (O1, O2, POZ, OZ) and
temporal region (left temporal region (FT7, T7, TP7) and right temporal region (FT8, T8, TP8)) (Figure 4.4).
Table 4.4: Regulatory Power from Different Regions of Brain
Alcoholic Control
Region Single Matching Non-matching Single Matching Non-matching
Central 0.7937 (20.7) 1.4460 (35.3) 1.1107 (25.9) 1.1527 (26.2) 1.5443 (23.7) 1.3102 (26.2)
Frontal 1.0878 (28.4) 0.8206 (20.0) 1.3754 (32.1) 0.8657 (19.7) 2.3712 (36.4) 1.0524 (21.0)
Occipital 0.6160 (16.1) 0.5620 (13.7) 0.5566 (13.0) 0.8485 (19.3) 0.8020 (12.3) 0.7883 (15.8)
Parietal 0.5611 (14.6) 0.7373 (18.0) 0.6344 (14.8) 0.5056 (11.5) 0.9956 (15.3) 1.0200 (20.4)
Temporal 0.7770 (20.3) 0.5301 (12.9) 0.6130 (14.3) 1.0327 (23.4) 0.7975 (12.2) 0.8294 (16.6)
Total 3.8356 4.0960 4.2900 4.4052 6.5106 5.0003
Figure 4.6 shows the topographic distribution of Sj from the final-selected net-
work of the two groups of subjects under the three experimental paradigms (single
image, matching, and non-matching images stimuli). For the single-image paradigm,
the control group and the alcoholic group have a big difference of regulatory power
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distribution on the scalp which can be observed from both Figure 4.6 and Table 4.3.
The left temporal and occipital regions have a stronger regulatory power than other
regions for controls compared with the alcoholic subjects. The only active region of
the alcoholic group is the occipital region which is in charge of visual reception, but
far less active compared with the controls. The top 10 electrodes for the single-image
paradigm for controls are much stronger than those of the alcoholic groups.
Figure 4.6: The regulatory power Sj , j = 1, . . . 64, for alcoholic group under stimuli: single
image (upper left), two matching images (upper middle), and single image (upper right),
and for control group under stimuli: single image (lower left), two matching images (lower
middle), and single image stimulus (lower right).
Compared with the single-image paradigm, the other two stimuli exhibit more
power in the central area. For the matching paradigm, in control subjects, other
than the left temporal and occipital regions, the central and prefrontal regions con-
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tribute substantially to the regulatory power in the matching task (Figure 4.6, mid-
dle bottom). The alcoholic group has the regulatory power mainly from the central
and right central area, and to a lesser extent from the left frontal area. The largest
between-group difference is that the control group has a considerably more regulatory
power from both the right and left frontal area which contains most of the dopamine-
sensitive neurons that are associated with reward, attention, and short-term memory
tasks. Both the control and alcoholic group show core regulatory power from the
occipital area which is the visual cortex in charge of sensory reception.
In contrast to the matching paradigm, under the non-matching paradigm, the
regulating strength from the right occipital area and the temporal area is more active
for control patients compared with the alcoholic group. This agrees with the observa-
tion that the occipital-temporal region is associated with visual memory during the
recognition task (Zhang et al., 1995).
The network for matching paradigm has less number of edges compared with
the non-matching paradigm. However, the signal strength is stronger in the cen-
tral, frontal and occipital area. The highly concentrated regulatory network for the
matching paradigm agrees with previous findings supporting repeated stimuli as a
physiological correlate of a “sharpening mechanism”. That is, neurons’ coding fea-
tures, which are not essential for processing a repeated stimulus are dropping out of
a cell assembly coding this object, and thus, yielding a more efficient cortical repre-
sentation of a stimulus. The lower regulatory power overall in the alcoholic group
compared to control group suggests a loss of effective connectivity. This may offer a
mechanistic understanding of alcoholism.
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4.6 Discussion
In this chapter, we propose a semiparametric model and integrated estimation
method, IIM-ODE, to estimate a network of ODE systems that accommodate non-
linear relationship between the dynamics of a target state variable with other reg-
ulators. IIM-ODE assists in explaining complicated biological dynamic network in
a more flexible, yet interpretable way, by capturing the nonlinear interactions by a
vector of regulation parameters under a nonparametric link function. Meanwhile,
we circumvent derivative estimation by directed modeling observations as integrated
ODE systems, which improves the asymptotic property. We also propose an efficient
algorithm to estimate a sparse network through regularization. We show that the
model is identifiable, the estimated network parameters estimated from IIM-ODE
are semiparametric efficient, and the algorithm performs adequately and efficiently
in empirical studies.
The first benefit of IIM-ODE is to capture multiple time-course datasets that
arise from a dynamic model with the same regulatory network structure, i.e., same
directed edges in the network, but different regulatory effect induced by the second
index score. The model is particularly appealing for applications exploring the influ-
ence of experimental settings for experimental data, or accommodating subject-level
heterogeneity. The second benefit of IIM-ODE is to construct effective network and
provide inference. The network parameters are useful for understanding how activ-
ity from one brain region is influenced by changes in other regions or changes in
experimental context.
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IIM-ODE can be extended to a partially linear single-index model in the form of
M
′
ik(t) = γkZi + γkWi(t) + fk(β
T
kMi(t)), in which the time-independent covariates
Zi and time-varying covariates Wi(t) are included additively as external factors or
inputs of the dynamical system. Lastly, constraints on the link function fk (e.g.,




In this work, we developed models and computational tools for two type of biomarkers.
For the longitudinal biomarker, we fulfilled several objectives. First, we developed
models with sigmoidal shape, in which the inflection point is random. The temporal
order of the inflection points of biomarkers can be determined through parameters.
Second, the biomarkers are jointly modeled by using a shared latent random variable
for each individual, and the random variable gives a utility score of the disease sever-
ity for an individual. Third, the role of genetic factors, environmental factors, and
cognitive reserve, in progression of the diseases are explored. Each biomarker can be
scaled into a common range on the vertical axis. Lastly, the future trajectory of an
individual can be predicted given baseline data.
For the high time-resolution biomarkers, we developed a semiparametric nonlinear
ODE model using multi-index model. The estimation is based on numerical integra-
tion, and the algorithm iterates between the estimation of the link function through
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Appendix A
Appendices for Chapter 2
A.1 M-step in EM Algorithm
In this section, only non-trivial update of the parameters in M-step is list. (γk, χ̃k)
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Hn(χ̃k,γk) = Hn(γk, χ̃k).
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where Mijk = Yijk − βT0kXi − β1ktijk.
(1) The posterior probability of Qik = 1 given vik and Wi is













(2) The posterior probability of Qik = 0 and Hijk = 0 given vik and Wi is







































































































































where (xj, wj) are the node and associated weight. We used 20 nodes for Wi and 10
nodes for vik. All posterior expectation can be calculated by first fixing Wi at a node,
and apply the approximation w.r.t vik, and then apply the approximation w.r.t Wi.
A.3 Simulation Results and the Motor Domain
Results
The simulation result for Scenario I is listed in Table A.1, A.2. The estimates for
markers in the motor domain are summarized in Table A.3.
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Table A.1: The Estimates of Simulation Data under Scenario I: Marker 1, 2∗
Marker Marker 1 Marker 2
Par Covariate True MeanB MedianB s.d. s.e. CP% True MeanB MedianB s.d. s.e. CP%
β0k Intercept 69.570 -0.371 -0.343 0.322 0.309 92 91.993 -0.258 -0.237 0.437 0.420 91
T1 -1.280 -0.117 -0.129 0.205 0.197 97 -2.038 -0.054 -0.049 0.228 0.218 94
CAG -7.549 -0.054 -0.083 0.198 0.190 96 -8.617 -0.079 -0.104 0.216 0.207 90
Gender 1.352 -0.087 -0.066 0.307 0.295 89 -5.201 -0.087 -0.097 0.406 0.390 91
Edu Yr 1.505 -0.153 -0.162 0.148 0.142 89 1.618 -0.139 -0.131 0.196 0.188 93
DCL -3.515 -0.076 -0.071 0.159 0.152 96 -3.296 -0.077 -0.080 0.156 0.150 93
Putamen 0.062 -0.014 -0.024 0.155 0.149 90 -0.570 0.036 0.036 0.196 0.188 90
β1k -0.241 0.001 0.000 0.007 0.006 90 -0.195 -0.001 -0.001 0.009 0.009 91
αk Intercept 8.696 0.016 0.030 0.088 0.084 87 12.214 0.004 0.001 0.082 0.079 89
T1 0.087 -0.027 -0.031 0.084 0.080 97 1.254 0.001 0.010 0.090 0.086 95
CAG 1.446 -0.047 -0.052 0.093 0.089 92 3.111 -0.011 -0.011 0.112 0.108 90
Gender 0.248 0.025 0.018 0.140 0.134 91 -0.393 0.004 -0.004 0.149 0.143 93
Edu Yr 0.799 -0.025 -0.019 0.067 0.064 91 0.629 0.001 0.000 0.076 0.073 93
DCL 0.370 -0.007 -0.010 0.064 0.061 96 0.683 0.011 0.015 0.064 0.062 95
Putamen -0.305 0.006 0.016 0.076 0.073 91 0.158 -0.012 -0.010 0.068 0.065 92
ηk Intercept -1.542 0.011 0.000 0.166 0.159 93 -2.326 0.049 -0.017 0.287 0.275 96
T1 -0.087 0.006 0.010 0.123 0.118 92 -0.326 0.012 0.014 0.160 0.154 98
CAG -1.349 0.021 -0.020 0.225 0.216 88 -2.148 0.049 0.046 0.337 0.323 89
Gender 0.700 -0.028 -0.037 0.235 0.226 90 0.421 -0.012 0.007 0.315 0.302 93
Edu Yr 0.037 0.013 0.029 0.107 0.103 89 -0.202 0.032 0.031 0.137 0.131 91
DCL 0.310 -0.012 -0.028 0.124 0.119 94 0.147 -0.001 -0.006 0.151 0.145 96
Putamen 0.190 0.006 0.017 0.113 0.108 88 -0.363 0.005 0.012 0.164 0.158 91
θk T1 12.529 0.984 0.988 0.087 0.084 92 12.529 0.984 0.988 0.087 0.084 92
CAG 2.109 0.204 0.204 0.114 0.109 94 2.109 0.204 0.204 0.114 0.109 94
Gender 0.812 -0.152 -0.142 0.154 0.147 91 0.812 -0.152 -0.142 0.154 0.147 91
Edu Yr 1.629 0.153 0.158 0.074 0.071 89 1.629 0.153 0.158 0.074 0.071 89
DCL 0.643 0.057 0.061 0.081 0.078 97 0.643 0.057 0.061 0.081 0.078 97
Putamen -0.186 0.021 0.011 0.085 0.082 96 -0.186 0.021 0.011 0.085 0.082 96
bk -0.837 -0.003 -0.004 0.029 0.028 92 -0.774 0.001 0.002 0.030 0.029 93
µk 42 0.164 0.177 0.107 0.102 89 43 0.139 0.136 0.112 0.108 89
χk 1 -0.080 -0.081 0.008 0.007 91 0.8 -0.075 -0.074 0.007 0.007 91
σvk 2 -0.127 -0.113 0.077 0.074 92 2 -0.107 -0.104 0.070 0.067 93
σεk 1 -0.075 -0.074 0.014 0.013 91 1 -0.094 -0.094 0.016 0.016 92
∗: In the table, the true parameters are listed in the column “True”. The column “MeanB” and “MedianB” is the mean
and median bias of estimates from 100 simulation data. The s.d. is the standard deviation of the estimates based on 100
simulation data and the s.e. is the average standard error of the estimates from the bootstrap samples. The coverage
probability is for 95% CIs based on of the bootstrap estimates.
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Table A.2: The Estimates of Simulation Data under Scenario I: Marker 3, 4∗
Marker Marker 3 Marker 4
Par Covariate True MeanB MedianB s.d. s.e. CP% True MeanB MedianB s.d. s.e. CP%
β0k Intercept 120.287 -0.371 -0.382 0.640 0.615 93 45.423 -0.399 -0.351 0.323 0.340 91
T1 0.130 -0.061 -0.045 0.296 0.284 96 -3.370 -0.038 -0.050 0.233 0.178 95
CAG -10.728 -0.145 -0.153 0.256 0.246 94 -5.481 -0.024 -0.025 0.185 0.203 95
Gender 4.182 -0.126 -0.125 0.532 0.511 89 2.227 -0.036 -0.048 0.336 0.300 90
Edu Yr 3.568 -0.292 -0.300 0.221 0.213 93 0.513 -0.045 -0.053 0.120 0.119 91
DCL -3.086 -0.084 -0.076 0.237 0.227 94 -1.554 0.001 0.004 0.131 0.135 91
Putamen 0.354 0.064 0.089 0.243 0.233 97 -2.123 0.047 0.061 0.153 0.133 92
β1k -0.334 0.000 -0.001 0.012 0.011 98 -0.051 -0.001 -0.002 0.006 0.006 96
αk Intercept 16.727 0.030 0.026 0.149 0.143 93 8.674 0.019 0.013 0.109 0.073 89
T1 1.190 -0.031 -0.015 0.122 0.117 95 1.264 0.004 -0.007 0.138 0.075 93
CAG 3.805 -0.027 -0.057 0.144 0.139 93 2.546 -0.011 -0.010 0.115 0.092 95
Gender -1.547 -0.013 0.002 0.181 0.173 92 -1.445 0.000 0.010 0.180 0.118 91
Edu Yr 0.273 -0.008 0.001 0.103 0.099 93 0.809 0.000 -0.004 0.067 0.053 93
DCL 0.664 -0.002 0.001 0.088 0.085 96 0.326 -0.002 -0.003 0.076 0.044 95
Putamen 0.494 -0.010 -0.006 0.089 0.086 94 0.721 -0.002 -0.005 0.109 0.066 92
ηk Intercept -1.535 -0.005 -0.033 0.207 0.199 92 -1.014 0.002 -0.002 0.212 0.180 94
T1 -0.121 0.017 0.010 0.145 0.140 95 -0.279 -0.014 -0.004 0.160 0.147 94
CAG -1.388 0.021 0.003 0.246 0.236 92 -1.332 -0.051 -0.046 0.258 0.194 89
Gender 0.368 0.035 0.033 0.285 0.274 91 -0.017 -0.043 -0.025 0.287 0.235 92
Edu Yr 0.178 -0.019 -0.020 0.110 0.105 92 -0.023 -0.014 0.001 0.120 0.119 95
DCL -0.206 -0.017 -0.007 0.138 0.132 93 -0.612 0.000 -0.022 0.138 0.144 91
Putamen -0.557 0.003 0.004 0.148 0.142 91 0.591 0.010 0.028 0.174 0.136 97
θ T1 12.529 0.984 0.988 0.087 0.084 96 12.529 0.984 0.988 0.067 0.087 96
CAG 2.109 0.204 0.204 0.114 0.109 95 2.109 0.204 0.204 0.102 0.114 95
Gender 0.812 -0.152 -0.142 0.154 0.147 91 0.812 -0.152 -0.142 0.127 0.154 91
Edu Yr 1.629 0.153 0.158 0.074 0.071 92 1.629 0.153 0.158 0.060 0.074 92
DCL 0.643 0.057 0.061 0.081 0.078 97 0.643 0.057 0.061 0.066 0.081 97
Putamen -0.186 0.021 0.011 0.085 0.082 96 -0.186 0.021 0.011 0.064 0.085 96
bk -0.833 0.009 0.007 0.033 0.032 92 -0.562 0.001 0.000 0.025 0.023 95
µk 44 0.150 0.153 0.104 0.099 95 45 0.186 0.176 0.160 0.118 92
χk 0.6 -0.076 -0.077 0.008 0.007 92 0.4 -0.076 -0.078 0.020 0.009 94
σvk 2 -0.167 -0.168 0.111 0.107 94 2 -0.118 -0.116 0.074 0.068 93
σεk 1 -0.140 -0.140 0.020 0.019 91 1 -0.066 -0.066 0.011 0.013 92
∗: In the table, the true parameters are listed in the column “True”. The column “MeanB” and “MedianB” is the mean
and median bias of estimates from 100 simulation data. The s.d. is the standard deviation of the estimates based on 100
simulation data and the s.e. is the average standard error of the estimates from the bootstrap samples. The coverage
probability is for 95% CIs based on of the bootstrap estimates.
A.4 Variable Descriptions
TMS = total motor score from the Unified Huntington Disease Rating Scale (UH-
DRS) Stern et al., 1994. Standardized ratings of oculomotor function, dysarthria,





































Estiamted Average Curve and Asymptote
Truth Curve and Asymptote
Figure A.1: The simulation data with the true population average curve and the two
asymptotes (black lines), and the estimated average curve and the asymptotes (red dashed
lines) under Scenario I.
Brady = bradykinesia subscale from the UHDRS. Rating of abnormal slowness or
rigidity of movement Stern et al., 1994.
Ocular = ocular subscale from the UHDRS. Rating of eye movement and tracking
ibid.
Chorea = Marsden and Quinn’s chorea severity scale ibid.
Stroop = Stroop Color, Inference and Word Test. It consists of three 45-second
trials. The first two trials (color identification and word reading) measure basic
attention and processing speed. In the first trial, participants must correctly identify
the color of ink patches on a stimulus card. In the second trial, participants read
the names of colors printed in black ink. In the third trial, the interference trial,
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participants must consistently inhibit an overlearned response by identifying the
color of ink (red, green, blue) that the stimulus color words are printed in rather
than reading the word aloud. Raw scores indicate the number of items correctly
completed per trial Golden and Freshwater, 1978.
SDMT = Symbol Digit Modalities Test. The SDMT is an adaptation of the
Wechsler Digit Symbol subtest that measures working memory, complex scanning,
and processing speed.
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Table A.3: Parameter Estimates of the Motor Markers from PREDICT-HD Data
Par Covariate †Motor s.e. †Oculo s.e. †Brady s.e. †Chorea s.e.
β0k Intercept 0.112 0.451 -0.948 0.247 0.300 0.376 -0.266 0.209
T1 0.300 0.147 -0.261 0.143 0.049 0.111 -0.053 0.098
CAG -0.234 0.098 -0.128 0.066 -0.192 0.072 -0.170 0.059
Gender 0.061 0.065 0.032 0.043 0.055 0.058 0.042 0.023
Edu Yr 0.128 0.083 0.059 0.052 0.079 0.058 0.039 0.035
DCL -0.085 0.069 -0.057 0.060 -0.278 0.062 -0.127 0.026
Putamen 0.329 0.075 0.290 0.066 0.275 0.052 0.235 0.043
β1k -0.051 0.010 -0.006 0.006 -0.035 0.008 -0.025 0.005
αk Intercept 0.721 0.105 0.808 0.183 0.524 0.111 1.109 0.058
T1 -0.018 0.120 0.157 0.072 0.004 0.090 0.148 0.065
CAG 0.039 0.131 0.073 0.061 -0.040 0.096 0.135 0.042
Gender 0.057 0.064 0.026 0.041 0.047 0.063 -0.042 0.025
Edu Yr -0.124 0.085 -0.060 0.045 -0.053 0.066 -0.051 0.029
DCL -0.514 0.081 -0.262 0.119 -0.055 0.076 -0.105 0.055
Putamen -0.210 0.090 -0.204 0.088 -0.159 0.090 -0.102 0.043
ηk Intercept -0.666 0.468 -1.019 0.512 -1.989 0.657 -0.279 0.284
T1 -0.462 0.666 -0.113 0.410 0.726 0.635 0.157 0.223
CAG -0.526 0.664 -0.757 0.820 -1.672 0.939 -0.244 0.298
Gender -0.146 0.306 0.229 0.188 0.067 0.498 -0.087 0.165
Edu Yr -0.262 0.519 -0.046 0.242 0.148 0.468 -0.037 0.181
DCL -0.752 0.434 -1.123 0.357 0.736 0.694 -0.515 0.162
Putamen 0.136 0.434 -0.396 0.444 -0.039 0.497 0.614 0.219
θ T1 9.982 0.263 9.606 0.362 9.606 0.362 9.606 0.362
CAG -0.282 0.266 0.080 0.383 0.080 0.383 0.080 0.383
Gender 0.174 0.221 0.447 0.237 0.447 0.237 0.447 0.237
Edu Yr 0.181 0.260 -0.190 0.247 -0.190 0.247 -0.190 0.247
DCL -0.558 0.180 -0.600 0.282 -0.600 0.282 -0.600 0.282
Putamen1 -0.309 0.212 -0.627 0.363 -0.627 0.363 -0.627 0.363
ck 0.326 0.077 0.279 0.064 0.156 0.075 0.426 0.061
bk -0.929 0.230 -0.644 0.186 -0.885 0.237 -0.589 0.143
µk 41.438 0.320 40.756 0.579 40.508 0.645 41.232 0.470
χk 1.231 0.060 1.356 0.089 1.381 0.078 1.215 0.046
σvk 0.476 0.031 0.363 0.053 0.425 0.023 0.344 0.040
σεk 0.549 0.016 0.492 0.076 0.484 0.012 0.377 0.033
†: Motor measures are used after − log(x+ 1) transformation.
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Appendix B
Appendices for Chapter 3
B.1 Proof of Model Identifiability
We prove the identifiability assuming Ni =∞. That is, model (3.4) is




1 + exp{−bk(tijk − µk − χkWi)}
]
+ νik + εijk.
We assume the following conditions:
Condition 1. We assume that observed time points are completely random and more-
over, there exist a positive proportion of n subjects with ti1k = t0 and ti2k = t1 for
two different fixed times t0 and t1.
Condition 2. With a positive probability, [1, Zi] has a full rank.
Condition 3. For k = 1, ..., K, we assume bk0 6= 0. Furthermore, we assume at least
one χk0 > 0. Without loss of generosity, assume χ10 > 0.
Condition 1 implies that a portion of subjects have biomarkers measured at two
fixed time points. Usually, since all subjects have baseline measurements, t0 can be
chosen as 0. Condition 2 is standard in linear regression models. Condition 3 implies
that all the biomarkers have a non-degenerate sigmoid shape trajectory and that at
least one biomarker is informative of the latent variable.
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Proof. We consider subject i in the set given in Condition 1. First, since
Cov(Yi1k, Yi2k) = σ
2
νk




we immediately conclude that σ2νk and σ
2
εk are identifiable.
Let ψ denote all the parameters including (θ, µ, χ, η, α, β). The likelihood function

































where Σi is a K × K diagonal matrix whose (k, k)-element is σ2νk + σ
2
εk. To prove
identifiability, we need to show that l(ψ) = l(ψ0) where ψ0 is the true parameter,
then ψ = ψ0. In the equality l(ψ) = l(ψ0), we fix Zi and Yi1k for all k 6= 1 so only
Yi11 is random. Since Σi is the same on both sides due to the identifiability of ν’s




























































































where we use subscript 0 to indicate the argument in which all the parameters take
the true values.






















































Thus, the left-hand side is a moment generating function of exp(g(W̃i)) if we vary




where g0 has the same expression as g except that all parameters are the true values.
From the one-to-one mapping property of the moment generating function, we
have
g(W̃i) = g0(W̃i). (B.2)




equivalent to the original Wi on the right-hand side diverging to ∞. The right-hand
side of (B.2) is dominated by −W 2i /2. To ensure (B.2) holds, it is necessary that
β1t0 + ai1ci1 = β10t0 + ai10ci10,
ai1(1− ci1) = ai10(1− ci10)
and
b1(t0 − µk1) = b10(t0 − µk10), b1χ1 = b10χ10.
Therefore, this implies the transformations from Wi to W̃i in (B.1) are the same. We



















1 + exp{−bk(t0 − µk − χkWi)}
])
k





















holds for any Yi1k’s and Wi with probability 1. By examining the coefficient of the
quadratic and linear terms for Yijk’s and Wi, we obtain
βkt0 + aikcik = βk0t0 + aik0cik0,
aik(1− cik) = aik0(1− cik0),
bk(t0 − µk) = bk0(t0 − µk0),
bkχk = bk0χk0 for k = 1, ..., K and θ
TZi = θ
T
0 Zi. We use the same argument to
subject i with ti2k = t1 so obtain the same equalities but replacing t0 by t1. Hence,
we immediately obtain
βk = βk0, bk = bk0, aik = aik0, cik = cik0, µk = µk0, χk = χk0, θ = θ0.
Finally, since [1, Zi] is full rank with probability 1, aik = aik0 and cik = cik0 yield
99
αk = αk0 and ηk = ηk0. The identifiability holds.
B.2 E-step in EM Algorithm


















(Cik − EikUik)TΣ−1ik (Cik − EikUik).
Therefore Uik conditioning on Cik,Wi follows distribution:















































in which Wi stays in Dik, B̃ik and Ãik through pijk. The conditional density for Wi
after integrating out Uik, k = 1, . . . , K is now
Wi













vk and θ in the M-
step includes
Ê[Qik· +Rijk·], Ê[(Qik· +Rijk·)





For updating (bk, µk, χk), the conditional expectation needed includes
Ê
[
(1−Qik·) exp{γ1ktijk + γ2k + γ3kWi}(tijk, 1,Wi)T




(1−Qik·) exp{γ1ktijk + γ2k + γ3kWi}(tijk, 1,Wi)T (tijk, 1,Wi)
{1 + exp(γ1ktijk + γ2k + γ3kWi)}2
]
where γ1k = bk, γ2k = −bkµk, γ3k = −bkχk. All of them can be easily computed using
double expectation:
Ê [g1(Qik·, Rijk·, vik)g2(Wi)] = Ê[Ê [g1(Qik·, Rijk·, vik)|Wi] g2(Wi)]
For g1(Qik·, Rijk·, vik) which is any less or equal than order 2 multiplication between
elements of Uik, the conditional expectation with respect to Wi is readily derived
from:
Ê([Qik·, Ri1k·, . . . , Rinikk·, vik]
T [Qik·, Ri1k·, . . . , Rinikk·, vik]|Wi)
= Ê[UikU
T
ik|Wi] = Dik + Ê[Uik|Wi]Ê[Uik|Wi]T
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Figure B.1: The simulated data with N,n = 100, 100 in Section 3.3. The black line is the
marginal mean of marker trajectory based on the true parameters, and the red line is the
marginal mean based on the estimates, both assuming the covariate is at sample mean.
The expectation with respect to Wi is computed using Gauss-Hermite quadrature.









































where (ωl, wl), l = 1, . . . , 10 are the roots of Hermite polynomials and corresponding
weights. In our simulation and application, we used 10 nodes. The estimation using
simulated data with Ni = 100 is shown in Figure B.1.
B.3 Dynamic Prediction of Future Trajectories
Posterior prediction of the future trajectory of each biomarker for a new individual
with certain covariates can be easily derived. For a subject with covariates X =
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[1T ,ZT ]T and some observed measures of each biomarker, the conditional distribution
of latent W given the observed data is readily available from the expression (B.3) by
plugging in the MLE for all parameters. The mean of the next observation given
observed data Dn is:
E[Yi,j+1,k|Dn] = E[E[Yi,j+1,k|Wi]|Dn]
where the first outer expectation is taken w.r.t posterior distribution of Wi given
observed data Dn. The inner expectation can be obtained directly from the form
of expectation, by plugging in E(Qi|Wi), E(vi|Wi) and E(Hi,j+1,k|Wi). Similarly, we
get the posterior variance by:
Var[Yi,j+1,k|Dn] = E[Var[Yi,j+1,k|Wi]|Dn] + Var[E[Yi,j+1,k|Wi]|Dn]
Note that the number of observed data or visit age for each biomarker does not need
to be the same.
A web-based online dynamic prediction application is developed (Figure B.2) by
using our model with MLE parameters which gives future prediction of the mean and
95% CI of the trajectory for a potential patient with the options of inputing covariates
and certain observed biomarker measures (Figure B.2). The CI of the trajectory is
calculated by plugging in the the 95% CI of the parameters using estimated s.d. of
the parameters. In addition, our method gives the posterior density of dik for each
biomarker to assist disease staging at a given age.
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Figure B.2: This Shiny App can predict the future disease trajectory with the 95% CI and
the posterior density of dk using the model under MLE parameter, at the individual level.
Shiny App for Prediction of HD The app is developed under R 3.3.2. Any user can
use the app by inputting a new patient’s baseline covariates and baseline observations
(the four neuroimaging biomarkers need to be ICV-standardized and multiplied by
104). The App is available at https://mingbest.shinyapps.io/multivis/
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Appendix C
Appendices for Chapter 4
C.1 Proof of Lemma 1
We prove the model identifiability under assumptions (C.1)-(C.3) in Section 4.3.
First, since E[Yik(tj)|Xi] = Mik(tj) and by assumption (C.3), we can identify Mik(t)
for any t ∈ [0, T ]. It remains to show that f(·, ·), βkj,αk are identifiable. Suppose



















where Zj = Mij(0), gk(·) = fk(·,αTkXi) and g̃k(·) = f̃k(·, α̃TkXi). Since (Z1, ..., Zp)T
has an interior point in its support (open and convex), according to Lin and Kulasek-
era, 2007, we obtain βkj = β̃kj and gk(·) = g̃k(·). The latter gives
fk(z,α
T




which is another single-index model for fixed z. From assumption 1 and using the
result in Lin and Kulasekera, 2007 again, we obtain αk = α̃k and fk(z, x) = f̃k(z, x).
C.2 Proof of Theorem 1
Let Pn denote the empirical measure based on Yi,Xi, i = 1, ..., n, P denote its
expectation and G =
√
n(Pn − P) be the empirical process. In the following proof,
we will omit the subject subscript i in the notations.
We first prove the consistency of (f̂k, β̂k, α̂k). According to the uniform bound in






|M̂ik(t)−Mik(t)| ≤ Op(nN−1/2a−1/2N log(a
−1
N )).
Therefore, the kernel estimators, M̂ik(t), converge uniformly to Mik(t) in a rate of
Op(n
−1) by condition (C.3). Furthermore, we immediately have
|M(t)| ≤ |M (0)|+K0t, t ∈ [0, T ],
for some constant K0. Since M (0), i = 1, . . . , n comes from a distribution with
bounded support, M(t) and M̂ (t) have finite moments and is bounded in probability.
Since β̂k and α̂k are bounded, by the subsequence argument, we can assume that
they converge almost surely to β∗k and α
∗
k, respectively. From condition (C.4) and
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uniformly in βk and αk with norm 1.
Define














where µ#(t) is the counting measure at each measurement time point with mass equal
to 1/N . Clearly,
Pnlk(Y,M̂ ; β̂k, α̂k, f̂k) ≤ Pnlk(Y,M̂ ;βk0,αk0, f̃k).
Using the approximation result for M̂ and the fact that the derivative of f̂k is bounded
by O(MnKn), it gives





















kX)ds : ‖βk‖ = ‖αk‖ = 1, fk ∈ Φnk, t ∈ [0, T ]
}
.
It can be easily shown that the function in Hn is Lipschitz continuous with respect
to βk and αk with coefficient of O(KnMn). Thus, the class
Fn =
{
lk(Y,M ;βk,αk, f̂k)− lk(Y,M ;βk0,αk0, f̃k) : ‖βk‖ = ‖αk‖ = 1, f ∈ Φnk, t ∈ [0, T ]
}
has a bracket covering number N[](ε,Fn, L2(P )) of order O(KnM2nε−(p+q)). Notice
|fk(βTkM )| ≤ O(Mn) so the envelope function of Fn is bounded above by O(M2n).





logN[](ε,Fn, L2(P ))dε ≤ O(M3n logKn). (C.3)











After replacing f̃k by fk0, we obtain
P
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≤ ε2n, t ∈ [0, T ].
(C.4)
Hence, for any given g(t,M (t)) that is bounded by 1 and differentiable with



































































































































k0X)|βTM(s),αTX] in β and α, and
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k0X)|β∗Tk M (s),α∗Tk X] = fk0(βTk0M (s),αTk0X).
By the identifiability in Lemma 1, we obtain β∗k = βk0 and α
∗
k = αk0. We further
have
∥∥∥β̂k − βk0∥∥∥2 + ‖α̂k −αk0‖2 ≤ Op(1)εn√KnMn. (C.6)





















According to the properties of the splines (De Boor, 1984), we have
Kn+M∑
j=1
|θ̂kj − θ̃kj|2 ≤ Op(1)(KnMn)5/2εn.
















so converges to zero in probability by condition (C.5).
To improve the convergence rate of the estimators, we can now restrict f̂k to the
following class of functions:
Φcnk :=
{
f(x) : ‖f‖W 1,∞(D) ≤ c
}
for some large constant c. We repeat the same arguments before but note that the




lk(Y,M ; β̂k, α̂k, f̂k)− lk(Y,M ;βk0,αk0, fk0)
]
≤ op(n−1/2) + op(K−2dn ) +O(n−1).
(C.7)












≤ op(n−1/2) + op(K−dn ). (C.8)
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We conclude


















≤ op(n−1/2) +Op(K−dn ).
Theorem 1 thus holds.
C.3 Proof of Theorem 2




















for any g, where ∇f(x, y) denotes the gradient of f , and a · b denotes the component















∣∣∣βTk0M (s) = y,αTk0X = x] = 0.
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The existence of the solution to the equation follows from the Fredholm theory. More-
over, h has bounded (d + 2)th derivatives following the smoothness of fk0 and the
smoothness of M(t). We let hn be the projection of h on Φnk so ‖hn − h‖L∞(D) =
O(K−dn ).




















































































































































We further expand the right-hand side of (C.9) and use the approximation of hn to







































∥∥∥β̂k − βk0∥∥∥2) +Op(√n ‖α̂k −αk0‖2) + op(1), (C.10)
where ∇2f denotes the Hessian matrix of f(x, y). Using the convergence rate in

































































































(β̂k − βk0, α̂k −αk0) + op(1).
Hence,
√
n(β̂k − βk0, α̂k − αk0)pk=1 converges in distribution to a mean-zero normal
distribution. Theorem 2 holds.
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